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1
evoluTion of neuromusCular bloCkaDe in anaesThesia: from 
Curare To sugammaDex
General anaesthesia is a pharmacologically induced state of the body that is charac-
terized by unconsciousness (hypnosis), pain relief (analgesia) and muscle relaxation 
(paralysis). It allows patients to endure invasive surgical procedures without cognition 
and pain perception. Every pharmacologic component of anaesthesia is essential for 
success. Hypnosis and analgesia are induced by agents that depress the central nervous 
system at various levels. They prevent somatic and cognitive arousal and suppress the 
sympathetic response to painful (surgical) stimuli. The combination of both agents is 
sufficient to induce and maintain general anaesthesia; however they do not fully de-
press all motor reflexes in every circumstance.1, 2 For example, even during adequate 
general anaesthesia, high intensity (surgical) stimuli can trigger reflexes that result in 
sudden movement of a patient. The addition of muscle relaxants to general anaesthesia 
prevents these sudden movements and ensures an immobile patient throughout a 
procedure. 
The use of muscle relaxation as a routine part of general anaesthesia has historically 
not been an easy matter of course. The first muscle relaxing agents were direct deriva-
tives of an agent called curare. Curare is naturally present in the jungle plants of the 
Chondodendron and Strychnos genus. Curare’s deadly characteristics were long known 
by jungle tribes, who used it as a poison on their hunting arrows. Curare induces a 
flaccid paralysis of all skeletal muscles by blocking the signal transmission from the 
nerve-end  to the muscle at the neuromuscular junction. This eventually causes death 
by respiratory arrest. Curare only exerts its muscle relaxing properties when it directly 
enters the bloodstream and is harmless when it is ingested by mouth. Hunted animals 
were therefore safe for consumption. Colonial expansion eventually brought curare to 
the attention of western scientists.3 Experiments with curare began in the mid-1800 and 
were led by important discoveries on neuromuscular transmission by Claude Bernard 
and others.4 Interestingly, these experiments took place at the same time ether and 
nitrous oxide inhalation anaesthesia became known.5, 6 However, in contrast to the rapid 
adoption of these hypnotic agents, it would take nearly a 100 years longer for muscle 
relaxants to become a part of anaesthesia. 
In 1942, Harold Griffith and Enid Johnson were the first to use a muscle relaxant (In-
tocostrin) during general anaesthesia.7 They sought a way to provide optimal surgical 
working conditions during abdominal surgery by ensuring an immobile patient. At that 
time, the only way to ensure an immobile patient during surgery was to use high doses 
of anaesthetic agents to maintain a deep level of general anaesthesia. Deep anaesthesia, 
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although applicable, comes with a variety of disadvantages, most notably prolonged 
recovery times and hemodynamic collapse. Muscle relaxation allowed for a reduction in 
the depth of general anaesthesia, whilst maintaining an immobile patient and ensuring 
good surgical working conditions. Four main purposes for the use of muscle relaxants 
during general anaesthesia were recognized by that time8:
To provide muscular relaxation required for abdominal surgery
To facilitate respiratory control during thoracic procedures
To ensure freedom of laryngospasm 
To reduce the amount of anaesthetic agents in whilst achieving the previous
The pioneering work of dr. T.C. Gray and others further shaped the technique of “light 
anaesthesia” with muscle relaxation and the control of respiration. This laid the basis 
of the well-known Liverpool anaesthetic technique.9, 10 However, the increasing use 
of muscle relaxants soon unfolded major concerns. In 1954, Beecher and co-workers 
reported a six fold increase in anaesthesia related mortality in cases were muscle relax-
ants were used.11 This association was noted in the period after anaesthesia and surgery 
had ended (i.e. the postoperative period). Incomplete recovery of neuromuscular block 
(NMB)  after anaesthesia has ended (known as postoperative residual curarization) causes 
persistent general muscle weakness in the early postoperative period. This condition 
interferes with normal breathing and is strongly associated with adverse respiratory 
events in the recovery ward.12 Postoperative residual curarization remains a common 
problem, even in the present day. Despite the availability of neuromuscular monitoring 
devices and reversal agents, incidences of 40-60% have been reported consistently in 
the literature over the last decades.13 
From a pharmacological view, the potential for postoperative residual curarization to 
occur is evident. The paralyzing effect of muscle relaxants last much longer than the 
effects of the hypnotic agents. For instance, an induction dose of rocuronium, a com-
monly used muscle relaxant with an intermediate duration, has an average recovery 
time of 50-60 minutes.14 In contrast, the time for a patient to awake after termination of 
a propofol and remifentanil infusion (a commonly used hypnotic and analgesic agent 
respectively) is less than 10 minutes.15 In addition, the recovery time of muscle relaxants 
is unpredictable and displays a large variation between patients.16 The use of muscle 
relaxants always bears a risk of incomplete recovery and the only way to fully preclude 
residual curarization is objective measurement of the level of neuromuscular block at 
the end of anaesthesia. 
Neuromuscular monitoring is one of the corner stones to prevent residual curarization. 
Currently, multiple commercially available neuromuscular monitoring devices are avail-
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1able. In this thesis, acceleromyography of the adductor pollicis muscle (device: TOF watch SX, Organon, the Netherlands) or compressomyography of the biceps muscle (device: 
TOF cuff , RGB medical devices, Spain) were used. All these devices work by the same 
principle: a peripheral nerve is stimulated by a low voltage current, which evokes a con-
traction in a nearby muscle (see fi g. 1 for schematic setup of the TOF watch). The mag-
nitude of the evoked muscle contraction refl ects the level of neuromuscular blockade. 
Several distinct stimulation modes exist, of which train-of-four and post-tetanic-count 
are the most common.17, 18 Train-of-four (TOF) stimulation is used to assess shallow and 
moderate levels of neuromuscular bock. A train-of-four consists of four short electrical 
stimuli which evoke four short muscle contractions (twitches). With increasing level of 
neuromuscular block, the twitches will fi rst reduce in strength and will eventually disap-
pear.18 In addition, the ratio of the fourth twitch relative to the fi rst twitch (TOF ratio) 
has to be recovered to at least 0.9 or 90% before the end of anaesthesia, to ensure that 
muscle strength is adequate. . Any TOF ratio below 0.9 is called residual curarization by 
defi nition and poses patients at risk for postoperative respiratory complications.19-21 
During a deep neuromuscular block, the train-of-four will not yield any muscle re-
sponses (i.e. TOF = 0 twitches). In this instance, the post-tetanic-count (PTC) method can 
be used to determine the exact depth of neuromuscular block. The post-tetanic-count 
method diff ers from the train-of-four method in that this stimulation mode begins with 
figure 1: Schematic setup of the TOF watch at the adductor pollicis muscle. Two electrodes are placed 
adjacent to the ulnar nerve. A current of 30-60 mA administered at the ulnar nerve will evoke a muscle 
contraction of the adductor pollicis muscle at the base of the thumb. A piezoelectric sensor placed at the 
distal end of the thumb records the acceleration of the thumb that is caused by the muscle contraction. The 
magnitude of the acceleration is a refl ection of the level of neuromuscular block.
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a prolonged current on the nerve (tetanic stimulus, 50Hz for 5 seconds). This results 
in a massive pre-synaptic release of acetylcholine in the neuromuscular junction. Ace-
tylcholine is the neurotransmitter that is primarily responsible for signal transmission 
between a nerve end and a muscle fi ber. The acetylcholine excess will exist for a short 
period of time, before it is broken down by the enzyme acetylcholinesterase. During 
this period, neuromuscular signal transmission is temporarily enhanced, so that 10 to 
20 short stimuli following the tetanic stimulus may evoke muscle responses during a 
deep neuromuscular block. The number of detectable twitches add up to form the post-
tetanic-count.17 In this thesis, a deep neuromuscular block is defi ned as a post-tetanic-
count of 1 to 2 twitches; a moderate neuromuscular block is defi ned as a train-of-four 
count of 1 to 3 twitches (see fi g. 2). Further reading about depth of neuromuscular block 
can be found in chapter 7.  
Neuromuscular monitoring has proven to be essential in reducing the incidence of post-
operative residual curarization,22-24 but other strategies exist. One of these strategies is 
to reverse any residual neuromuscular block before the end of anaesthesia. Neuromus-
cular reversal may be of equal importance as neuromuscular monitoring and in practice 
these strategies go hand in hand. Reversal techniques are aimed to signifi cantly speed 
up the recovery of neuromuscular block. Traditionally, this is achieved with the use of an 
acetylcholinesterase inhibitor (e.g. neostigmine). These agents reduce the breakdown of 
acetylcholine in the neuromuscular junction, resulting in enhanced neuromuscular sig-
nal transmission and competitive antagonism with the neuromuscular blocking agent.25 
However, acetylcholinesterase inhibitors have important intrinsic limitations. Reversal 
with these agents is often lengthy or incomplete and they cannot be used for reversal 
figure 2: Schematic illustration of depths of neuromuscular block.  The vertical bars represent the twitches 
of the thumb evoked by either TOF or PTC stimulation. The fi gure shows, from left to right, the typical 
course neuromuscular block (NMB) after a single administration of muscle relaxant. In the fi rst orange 
square, the twitches of the train-of-four disappear after the administration of a muscle relaxant. As the 
NMB deepens in the fi rst minutes after administration, all twitches of the TOF and PTC disappear (second 
square), leading to an intense NMB.  When the muscle relaxant starts to wear off , the twitches return, fi rst 
in the PTC (third square) and later on in the TOF (fourth and fi fth square). Eventually, as the NMB has com-
pletely recovered, the twitches in the train-of-four will again have equal strength. TOF= train-of-four; PTC 
= post-tetanic-count. 
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1of deep neuromuscular block.
26 Consequently, acetylcholinesterase inhibitors should be 
dosed well in anticipation of surgery-end and exclusively for reversal of shallow levels of 
neuromuscular block.27 Inappropriate use of acetylcholinesterase inhibitors still yields a 
high incidence of residual curarization and the associated respiratory complications.28
To reduce the risk for residual curarization, the depth of the neuromuscular block dur-
ing anaesthesia is often maintained at a shallow or moderate level to ensure prompt 
spontaneous recovery or easy reversal with an acetylcholinesterase inhibitor. In addition, 
a moderate depth of neuromuscular block is generally considered to be sufficient for 
abdominal muscle relaxation, ensuring good operating conditions (i.e. a “surgical block”). 
However, due to the evolution of surgical procedures from open to minimal invasive 
(laparoscopic) approaches, a moderate NMB may not be sufficient to maintain good 
surgical working conditions. To understand this, two things are important to realize. First, 
in laparoscopic surgery, space is often limited and muscle contractions can severely ham-
per the surgeon. Second, these muscle contractions can happen during a moderate NMB 
because the abdominal muscles and diaphragm are more resistant to muscle relaxants 
than other muscles in the body and require a larger dose to become fully paralyzed.29-31 In 
practice, this means that a deep NMB must be applied to fully relax all these muscles.1, 2, 30 
Until recently, the application of a deep NMB was very unpractical for routine use. As 
a deep NMB cannot be reversed with acetylcholinesterase inhibitors, it came with very 
long recovery times and a high risk of postoperative residual curarization. The introduc-
tion of sugammadex, a novel, selective reversal agent, took away these disadvantages. 
Sugammadex reversal is based on a new reversal principle, which substantially differs 
to the reversal principle of acetylcholinesterase inhibitors. Sugammadex is a modi-
fied, cyclic sugar molecule (y-cyclodextrin), which is able to encapsulate molecules of 
neuromuscular blocking agents with a steroidal structure (rocuronium, vecuronium and 
pancuronium).32 Encapsulation renders the muscle relaxant molecules unable to exert 
their effect and quickly terminates the muscle relaxing effect. The encapsulation process 
takes place in the plasma, happens on a 1 to 1 basis (i.e. 1 molecule sugammadex encap-
sulates 1 molecule rocuronium) and is irreversible (see fig. 3). Unlike acetylcholinesterase 
inhibitors, sugammadex is able to completely reverse a deep neuromuscular block in a 
very short period of time.33-35 
Sugammadex has opened the door for clinical application of deep neuromuscular block 
during general anaesthesia. The use of deep neuromuscular blockade may improve 
surgical working conditions over a standard (moderate) neuromuscular block during 
laparoscopic procedures. Especially in laparoscopic retroperitoneal prostatic and renal 
surgery, where space is very limited, surgical working conditions may largely depend 
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on a deep neuromuscular block. In addition, the intensity of sugammadex reversal 
compared to neostigmine reversal may reduce the occurrence of postoperative residual 
curarization. In this thesis, these two hypotheses were tested. Additionally, the eff ect of 
deep neuromuscular block and reversal of neuromuscular block with sugammadex on 
postoperative outcomes was assessed.
Thesis ouTline
This thesis is divided in four subsections. 
Section 1 presents two prospective studies about the eff ect of deep neuromuscular block 
on surgical conditions during laparoscopic retroperitoneal surgery (chapters 2 and 3). 
The eff ect of deep neuromuscular block and of sugammadex reversal on postoperative 
outcome is presented in section 2 (chapters 4 and 5). 
The methods and use of surgical rating scales in laparoscopic surgery are discussed in 
section 3 (chapter 6). 
Section 4 presents an overview of recent literature and places the results of this thesis 
in perspective (chapter 7). Finally, conclusions and applications and implications of the 










figure 3. Schematic illustration of neuromuscular transmission at the neuromuscular junction and the 
encapsulation of rocuronium by sugammadex in the blood plasma. Courtesy of MSD, not authorized for 
reproduction.
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The routine use of neuromuscular blocking agents reduces the occurrence of unac-
ceptable surgical conditions. In some surgeries, such as retroperitoneal laparoscopies, 
deep neuromuscular block (NMB) may further improve surgical conditions compared 
to a moderate NMB. In this study, the effect of deep NMB on surgical conditions was 
assessed.
methods 
Twenty-four patients undergoing elective laparoscopic surgery for prostatectomy or 
nephrectomy were randomized to receive moderate NMB (train-of-four 1–2 twitches, 
induced by atracurium and mivacurium) or deep NMB (post-tetanic count 1–2 twitches, 
induced by a high dose rocuronium). After surgery, NMB was reversed with neostigmine 
(moderate NMB), or sugammadex (deep NMB). During all surgeries, one surgeon scored 
the quality of surgical conditions using the five-point Leiden - surgical rating scale (L-
SRS) ranging from 1 (extremely poor conditions) to 5 (optimal conditions). Video images 
were obtained and 12 anaesthetists rated a random selection of images.
results 
Mean (SD) SRS was 4.0 (0.4) during moderate and 4.7 (0.4) during deep NMB (p <0.001). 
Moderate NMB resulted in 18% of scores at the low end of the scale (scores 1–3); deep 
block resulted in 99% of scores at the high end of the scale (scores 4 and 5). Cardio-
respiratory conditions were similar during and after surgery in both groups. Between 
anaesthetists and surgeon, there was poor agreement between scores of individual 
images (average k statistic 0.05).
Conclusions 
Deep NMB results in an improved quality of surgical conditions compared with moderate 
block in retroperitoneal laparoscopies, without compromise to the patients’  peri- and 
postoperative cardiorespiratory conditions.
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2
inTroDuCTion
Administration of muscle relaxation is essential in a variety of procedures since it causes 
an improvement of surgical conditions. For example, King et al. demonstrated that the 
routine use of muscle relaxants reduced the frequency of unacceptable surgical condi-
tions in radical prostatectomies.1 Improvement of surgical conditions may be even more 
important when the surgeon has to work in a narrow space surrounded by muscles such 
as in case of retroperitoneal laparoscopic surgery. It may be argued that in retroperitoneal 
laparoscopic surgery, a deep neuromuscular block (NMB), with train-of-four (TOF) values 
of 0 and a post-tetanic-count (PTC) of 1-2, would further improve working conditions. 
However, the use of deep NMB may come with complications including long-reversal 
times, incomplete recovery of neuromuscular function compromising respiratory and 
upper airway function, or the return of NMB following a period of seemingly normal 
neuromuscular function (re-curarization).1-3 
The development of sugammadex enables rapid reversal of deep NMB. Sugammadex 
is a modified γ-cyclodextrin, especially created to bind the free plasma molecules of the 
muscle relaxant rocuronium to which is has high affinity.4 Recent studies demonstrate 
that sugammadex produces rapid reversal of deep NMB following administration of 
high dose rocuronium.5 Theoretically, the combination of rocuronium and sugammadex 
makes it possible to achieve deep NMB and consequently further improve surgical con-
ditions in retroperitoneal laparoscopic surgery without the fear for prolonged reversal 
times or incomplete recovery of neuromuscular function. However, the association 
between the depth of NMB and surgical conditions has not been evaluated as yet. 
In the current study we investigated the effect of a deep neuromuscular block (TOF 
count 0, PTC 1-2 twitches) against a moderate block (TOF count 1-2 twitches) on 
surgical conditions in patients undergoing retroperitoneal laparoscopic surgery for a 
prostatectomy or (partial) resection of a kidney. Surgical conditions were rated using a 
5-point surgical rating scale (SRS) by one dedicated surgeon with ample experience in 
such surgery (RB). We hypothesize that deep NMB is associated with improved ratings by 
the surgeon. Secondary end-points of our study included the assessment of the level of 
agreement between anaesthetists (the providers of the NMB agents and consequently 
responsible for a significant part of surgical conditions) and surgeon in terms of their 
rating of the surgical conditions. To that end, 30-s video images of the surgical field, 
obtained at the time of scoring by the surgeon, were rated by the anaesthetists.
24 Chapter 2
meThoDs
The study (acronym BLISS study: effect of deep BLock on Intraoperative Surgical 
conditions, perioperative hemodynamic status and respiratory parameters 
following reversal with Sugammadex in patients undergoing laparoscopic renal 
and prostate surgery. was carried out between November 2012 and February 2013 at 
the Leiden University Medical Centre (Leiden, the Netherlands) and was performed ac-
cording to guidelines of Good Clinical Practice and Good Research Practice. Approval 
of the protocol was obtained from the institutional review board (Commissie Medische 
Ethiek, Leiden, the Netherlands). Patients scheduled to undergo an elective laparo-
scopic prostatectomy or nephrectomy (partial or total), were approached 2 weeks prior 
to surgery and received oral and written information about the study. All patients who 
were willing to participate gave written informed consent before enrolment. The study 
was registered at clinicaltrials.gov (NCT01361149); the protocol was published earlier 
online.6 The design of the study was randomized (deep neuromuscular block against 
standard or moderate block) and blinded (the surgical team, the research team and the 
anaesthetists that scored the video were all blinded to the treatment); the attending an-
aesthetist was not blinded. Randomisation was performed using a computer-generated 
randomisation code. The code was presented to the attending anaesthetist who pre-
pared the medication and took care of patient dosing during anaesthesia. 
Patients enrolled in the study had prostate or renal disease and were all eligible for 
surgical resection by laparoscopic approach. All procedures were performed by one 
surgeon (RB). Excluded from participation were patients with ASA class > III, age < 18 
years, inability to give informed consent, known or suspected neuromuscular disease, 
allergy to medication to be used during anaesthesia, a (family) history of malignant 
hyperthermia, renal insufficiency (serum creatinine > 2 times normal or urine output 
< 0.5 mL.kg-1.h-1 or glomerular filtration rate < 60 mL.h-1, or proteinuria), previous retro-
peritoneal surgery, and a body mass index of 35 kg.m-2 or greater. 
Perioperative protocol
All patients received total intravenous anaesthesia with propofol and sufentanil. Dur-
ing the procedure routine monitoring was applied: electrocardiography, blood pres-
sure, heart rate, electroencephalographic monitoring using a bi-spectral index (BIS) 
module (Philips, Eindhoven, the Netherlands). Propofol dosing was such that BIS values 
remained within the range of 40 to 50. Additionally, the cardiac output was measured 
non-invasively using an inflatable finger cuff attached to the Nexfin haemodynamic 
monitor (bmeye, Amsterdam, the Netherlands).  
With respect to neuromuscular blockade the patients were randomly assigned to one 
of two treatment groups:
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Group 1: Moderate neuromuscular block, in which the goal was to realize a moderate 
neuromuscular block (train-of-four 1-2 twitches). Neuromuscular blockade was induced 
with a bolus dose of atracurium 0.5 mg.kg-1, followed by a continuous infusion of mi-
vacurium 0.5 mg.kg-1.h-1. In case of deviations from the target train-of-four values, the 
pump speed could be increased or decreased, or a bolus dose could be given. This was 
left to the discretion of the attending anaesthetist. We used atracurium/mivacurium in 
Group 1 rather than low-dose rocuronium, as this combination is the current standard 
of care in our hospital. This approach enables us to compare our current local practice 
against a new paradigm, which is deep NMB for the chosen surgical procedures. 
Group 2: Deep neuromuscular block, in which the goal was to realize a block of zero 
twitches in the train-of-four but 1-2 twitches in the post-tetanic-count. To that end, 
patients received a loading dose of rocuronium 1.0 mg.kg-1 followed by a continuous 
infusion of 0.6 mg.kg-1.h-1. In case of deviations from the target train-of-four and post-
tetanic-count, the pump speed could be increased or decreased, or a bolus dose could 
be given. This was left to the discretion of the attending anaesthetist. 
In case of poor or extreme poor surgical conditions (as scored by the surgeon, see 
below), mivacurium or rocuronium infusion rates were increased by 20% after the ad-
ministration of a bolus dose of 15 mg. 
At the end of surgery all patients received a reversal agent: neostigmine following 
a moderate NMB block (neostigmine 1-2 mg combined with atropine 0.5-1 mg) and 
sugammadex (4 mg.kg-1) following a deep NMB block. Extubation occurred when the 
train-of-four ratio > 0.9.
Administration of all drugs was performed by the attending anaesthetists and not 
corresponded to the surgical team or the anaesthesia research team. 
monitoring
Neuromuscular function using an acceleromyograph was measured at the wrist (TOF-
watch-SX, MSD BV, Oss, the Netherlands). The TOF-watch delivers an electrical stimulus 
to the ulnar nerve and measures contractions of the adductor pollicis muscle (causing 
adduction of the thumb) through a sensor attached to the tip of the thumb. The thumb 
was placed in a flexible adaptor that applied a constant preload to the thumb. Before 
administration of any NMB agent the device was calibrated according the specifications 
of the manufacturer. To that end, before administration of any neuromuscular block-
ing agent, but after induction of general anaesthesia, the following procedures were 
conducted to standardize the neuromuscular monitoring: (1) application of a tetanic 
ulnar nerve stimulation (50 Hz for 5 seconds); (2) calibration of the TOF watch; and (3) 
performing a series of TOF measurements ensuring that the TOF ratio differs by less than 
5% between measurements. If the TOF ratio differed by more than 5% the TOF watch was 
recalibrated. The TOF ratio was normalised to the baseline values obtained during the 
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calibration procedure. After these steps the neuromuscular blocking agent was adminis-
tered according to protocol. The number of thumb twitches upon electrical stimulation 
of the ulnar nerve was measured and recorded. At 15-min intervals the train-of-four was 
measured and in case of TOF count = 0, this was followed by the post-tetanic-count. In 
our study a TOF count of 1-2 twitches reflects a standard block and a PTC of 1-2 twitches 
reflects a deep NMB. Finally, when a TOF count of 4 twitches was present, the ratio of the 
fourth to the first twitch was determined (the TOF ratio).
leiden - surgical rating scale (l-srs)
During the laparoscopic procedure the surgeon scored the surgical working conditions 
at 15 min intervals according to a 5-point ordinal scale ranging from 1 (extremely poor 
conditions) to 5 (optimal conditions); Table 1. Extremely poor (score 1) indicates that 
the surgeon is unable to work due to coughing or due to the inability to obtain a visible 
field because of inadequate muscle relaxation; poor (score 2) indicates that there is a 
visible field but the surgeon is severely hampered by inadequate muscle relaxation with 
continuous muscle contractions and/or movements; acceptable (scores 3) indicates 
that the there is a wide visible field but muscle contractions and/or movements occur 
regularly; good (score 4) indicates a wide working field with sporadic muscle contrac-
tions and/or movements; and optimal (score 5) indicates a wide visible working field 
without any movement or contractions. In case of a sudden deterioration of conditions 
additional measurements could be added. The feasibility of this method of scoring was 
investigated during 5 surgical procedures not included in the study.
Table 1. The Leiden- surgical rating scale (L - SRS)
1 extremely poor conditions: The surgeon is unable to work due to coughing or due to the 
inability to obtain a visible laparoscopic field because of inadequate muscle relaxation. 
Additional muscle relaxants must be given.
2 Poor conditions: There is a visible laparoscopic field but the surgeon is severely hampered by 
inadequate muscle relaxation with continuous muscle contractions and/or movements with 
the hazard of tissue damage. Additional muscle relaxants must be given.
3 acceptable conditions: There is a wide visible laparoscopic field but muscle contractions 
and/or movements occur regularly causing some interference with the surgeon’s work. There 
is the need for additional muscle relaxants to prevent deterioration. 
4 good conditions: There is a wide laparoscopic working field with sporadic muscle 
contractions and/or movements. There is no immediate need for additional muscle relaxants 
unless there is the fear for deterioration. 
5 optimal conditions: There is a wide visible laparoscopic working field without any 
movement or contractions. There is no need for additional muscle relaxants.
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video images
Each time the surgeon rated the surgical conditions a video image of 30 seconds was cap-
tured using a camera connected to the endoscopic probe placed in the retroperitoneal 
surgical space. The procedure was such that the images collected give a visual indication 
of the surgical condition at the time of scoring. A randomized subset of these images (n 
= 10) was presented to twelve anaesthetists with ample experience in giving anaesthesia 
for urological laparoscopic procedures. They were asked to give a rating to the surgical 
condition using the same 5-point scale as used by the surgeon. These anaesthesia experts 
were blinded to the level of neuromuscular blockade and goals of the study. 
Data acquisition
The following clinical variables were collected on the case record form for further analy-
sis: anaesthesia-related parameters (drug dosages, bi-spectral index, time from reversal 
to optimal extubation conditions (TOF ratio > 0.9)), haemodynamic parameters (blood 
pressure, heart rate, cardiac output, cardiac index), ventilatory parameters (tidal volume, 
breathing rate, breathing pressure), surgical parameters (L-SRS, intra-abdominal pres-
sure, duration of surgery) and post-anaesthesia care-related parameters (time spent in 
the post-anaesthesia care unit, respiratory rate, oxygen saturation, pain score (on an 
11-point numerical rating scale from 0, no pain, to 10, most severe pain imaginable), 
occurrence of nausea/vomiting and sedation (on a 5-point scale ranging from 0, normal 
alertness to 5, not aroused by a painful stimulus)). Recurrent observations were made at 
15-min intervals both during anaesthesia and in the post-anaesthesia care unit.
sample size and statistical analysis
The sample size was based on the expectation of the surgeon for the distribution of 
the surgical ratings between the two treatment conditions: rating during the moderate 
block = 5 occurs in 10% of cases, 4 in 20%, 3 in 55% 2 in 10% and 1 in 5%; rating during 
the deep block = 5 in 70% of cases, 4 in 20%, 3 in 10%, 2 in 0% and 1 in 0%. These 
anticipated frequencies result in an odds ratio of 21 for optimal conditions (SRS 5) versus 
non-optimal conditions (SRS < 5). Ten-thousand simulations were performed to obtain 
the power for a given sample size with moderate block as a fixed distribution and a 
simulated distribution of the deep block condition assuming proportionality of the odds 
ratio with an odds ratio of 21 and analysing the results with a proportional odds model 
using the score test. The power ranged from 82% at a sample size of 14 (7 in each group) 
to 97% (n = 12/group). A sample size of 24 was chosen to take into account any margin 
of uncertainty around the effect size. 
The data analysis was based on the intent-to-treat approach. The primary end-point 
of the study was the influence of the depth of the neuromuscular block on the surgical 
rating scale. For each patient the final score was the average of all 15-min SRS values. 
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The treatment effect on the final score was tested using a t-test (SigmaPlot version 12.5, 
Systat Software Inc., San Jose, CA, USA). Secondary end-points were (1) the assessment 
of the level of agreement between anaesthetists and surgeon in terms of their rating 
of the surgical conditions; and (2) the effects of level of neuromuscular block on hae-
modynamic variables during surgery, time to TOF > 0.9, and relevant variables in the 
post-anaesthesia care unit (pain rating, sedation levels, cardiorespiratory variables). All 
variables were averaged over time to get an indication of their mean value. Treatment 
effects were evaluated on the average data by t -test. 
The scores of each of the 12 anaesthetists were compared with that of the surgeon’s 
score using the kappa statistic (also known as Cohen’s kappa) and population Bland 
Altman analysis.7-9 The kappa statistic calculates the agreement between a pair of scores 
over and above what is expected from chance, where kappa = [P(A) – P(E)]/[1 – P(E)], P(A) 
is the proportion of scores that agree and P(E) the proportion of scores that would agree 
by chance.7, 9 Kappa values between 0 and 0.2 are indicative of poor to slight agreement, 
values between 0.2 and 0.4 indicate fair agreement, 0.4 to 0.6 moderate agreement, 
0.6 to 0.8 substantial agreement, and 0.8 to 1 near complete to complete agreement.10 
Bland Altman plots give the difference between paired measurements (scores) against 
the mean of the values, which results in values for bias and limits of agreement to de-
scribe how closely measurements from two sources are related.8
All values presented are mean ± SD unless otherwise stated.  p-values < 0.05 were 
considered significant.
resulTs
A total of thirty patients were screened. In four patients one or more exclusion criteria 
were met. The others were randomized. Two patients withdrew consent before treatment; 
two others replaced them. See Fig. 1 for the flow chart of the study. Patient characteristics 
are given in Table 2 showing that the two treatment groups were similar in physical char-
acteristics, gender, types of surgery and haemodynamic variables. Duration of surgery 
was similar between treatment groups and ranged from 80 to 240 min with average 
surgical times of 141 and 144 min for standard care and deep NMB, respectively (Table 3).
anaesthesia 
Depth of anaesthesia, as measured by the bi-spectral index of the electroencephalo-
gram (BIS), was similar between treatment groups (moderate block 42 (5) vs. deep block 
44 (6)). Neuromuscular block in patients receiving a standard treatment was moderate 
with an average TOF count of 2.2 (0.9) twitches during surgery. Patients receiving a deep 
neuromuscular block had zero twitches in the TOF and 1.6 (1.5) twitches in the post-
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tetanic count. During surgery the dosages of the anaesthetic (propofol) or analgesic 
(sufentanil), the intra-abdominal pressure and haemodynamic variables were similar 





Withdrawal of consent: n=2
Allocated to intervention: n=24
n=12n=12
Moderate NMB (TOF=1–2) Deep NMB (PTC=1–2)
figure 1. Study flow chart.





Prostate surgery (n) 7 7
Renal surgery (n) 5 5
Gender (M/F) 10/2 10/2
Age (median, range) 59 (28-74) 60 (24-70)
Weight (kg) 83 (14) 83 (10)
Height (cm) 180 (10) 180 (9)
BMI (kg.m-2) 25.8 (3.2) 25.9 (3.9)
BP systolic (kPa) 19.6 (2.1) 18.9 (1.5)
BP systolic (mm Hg) 147 (16) 142 (11)
BP diastolic (kPa) 11.2 (2.2) 11.5 (1.6)
BP diastolic (mmHg) 84 (15) 86  (12)
HR (min-1) 71 (12) 73 (15)
CO (L.min-1) 5.9 (1.6) 5.8 (2.4)
CI (L.min-1.m-2) 3.0 (0.8) 3.1 (1.0)
BMI is body mass index, BP: blood pressure, HR: heart rate, CO: cardiac output and CI: cardiac index. Hae-
modynamic measurements were obtained prior to induction of anaesthesia. Values are mean (SD) unless 
stated otherwise.
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rating of surgical conditions during laparoscopic surgery 
The rating of the surgical field was significantly different between treatments with a 
mean rating of 4.0 ± 0.4 (range 3.5 to 4.5, median 3.9) during a moderate NMB with 
TOF count of 1-2 twitches and 4.7 ± 0.4 (range 4.0 to 5.0, median 4.9) during a deep 
block with PTC of 1-2 twitches (p < 0.001, Figure 2). The distribution of all ratings taken 
during surgery is given in Figure 3. From these data the significant difference between 
the moderate (TOF count 1-2 twitches) and deep (PTC 1-2 twitches) blocks is apparent 
from the fact that 18% of scorings during moderate block was in the SRS range of 1-3 
(scores rated as less than good), while 99% of scoring in the deep block was in the SRS 
range 4-5 (good and excellent scores). Variability in the individual ratings was higher for 
a block with TOF count = 1-2 twitches (mean coefficient of variation of ratings of surgical 
sessions 26%) compared to block with TOF = 0 and PTC = 1-2 (5%). 
Table 3. Measurements during surgery
moderate nmb Deep nmb 
Duration of surgery (min, range) 141 (80-240) 144 (90-195)
BIS 42 (5) 44 (6)
Propofol (g) 1.6 (0.8) 1.6 (0.4)
Sufentanil (μg) 73 (30) 78 (22)
Rocuronium (mg) - 223 (81)
Atracurium (mg) 37 (10) -
Mivacurium (mg) 41 (24) -
Train-of-four count 2.2 (0.9) 0
Post-tetanic-count - 1.6 (1.5) 
Leiden – surgical rating scale 4.0 (0.4)     4.7 (0.4) * 
Retroperitoneal pressure (kPa) 1.5 (0.5) 1.4 (0.2)
BP systolic (kPa) 15.3 (2.6) 15.4 (1.7)
BP systolic (mmHg) 115 (20) 116 (13)
BP diastolic (kPa) 9.1 (0.9) 9.2 (1.2)
BP diastolic (mmHg) 68 (7) 69 (9)
HR (min-1) 67 (10) 69 (13)
CO (L.min-1) 4.9 (1.4) 5.6 (2.0)
CI (L.min-1.m-2) 2.5 (0.8) 2.8 (0.9)
* p < 0.001 vs. moderate NMB. 
NMB: neuromuscular block, BIS: bi-spectral index, TOF: train-of-four, PTC: post-tetanic-count, L-SRS: 5-point 
Leiden - surgical rating scale, BP: blood pressure, HR: heart rate, CO: cardiac output and CI: cardiac index. 
Values are mean (SD) unless stated otherwise.
Deep NMB and surgical conditions during laparoscopic retroperitoneal surgery 31
2
measurements following surgery
Reversal of the neuromuscular block in patients with a deep block with sugammadex 
resulted in acceptable extubation conditions (TOF ratio > 0.9) after 5.1 (2.4) min. In 
contrast, similar extubation conditions were obtained after 10.9 (4.9) min (p < 0.01) in 
patients with a TOF count of 1-2 twitches and reversal with neostigmine. In the post-
anaesthesia care unit, no differences were observed in respiration, pain and sedation 



















Moderate NMB Deep NMB
p < 0.01
figure 2. Surgical ratings by the surgeon during 
laparoscopic surgeries using the 5-point Leiden - 
surgical rating scale (see Table 1). Squares denote 
the individual mean ratings obtained during sur-
gery. Circles are the mean of the means ± SD. NMB: 
neuromuscular block












































figure 3. Distribution of the surgical ratings obtained during standard of care (a) and during deep neuro-
muscular block (b). NMB is neuromuscular block.
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rating of surgical condition by anaesthetists 
A random set of 10 video images was scored by 12 anaesthetists. The distribution of the 
surgeon’s ratings of these 10 images is given in Figure 4A; the corresponding distribu-
tion of ratings of the anaesthetists is given in Figure 4B. Compared to the surgeon their 
ratings were skewed to the right and agreement with the surgeon’s ratings was poor 
(agreement between scores ranged from 0 to 40%). The kappa statistic was 0.05 (range 
-0.25 to 0.25). The Bland Altman analysis resulted in a significant bias of -0.43 (0.21; p = 
0.03) and large limits of agreement of 2.87 and –3.72, and a between-subject variance 
of 0.25 (Figure 4C). 
Table 4. Measurement following surgery
moderate nmb Deep nmb 
Sugammadex (mg) - 380 (101)
Neostigmine (mg) 1 (0) -
Time to TOF ratio > 0.9 (min) 10.9 (4.9) 5.1 (2.4)
Time in PACU (min) 86 (19) 86 (25)
SpO2 (%) 98.6 (1.8) 98.2 (1.4)
Breathing rate (min-1) 14.5 (2.2) 14.5 (2.2)
Pain score (11-point scale) 2.6 (1.6) 2.1 (2.2)
Sedation score (5-point scale) 2.0 (0.6) 1.3 (1.0)
TOF is train-of-four count, PACU: post-anaesthesia care unit and SpO2: arterial haemoglobin oxygen satura-
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figure 4. a. Distribution of scorings obtained from a random sample of 10 video snippets scored by the 
surgeon. b. Distribution of scorings obtained from a random sample of 10 video snippets scored by the 
surgeon and a group of 12 anaesthetists. C. Population Bland Altman analysis of the scorings from anaes-
thetists and surgeon. The continuous horizontal line is the bias; the dotted line the limits of agreement. The 
size of the dots represents the number of (overlapping) data points, which range from 1 for the smallest 
dots (1,0) and (1.5,-0.5), to 16 for the largest dot (4,-2).
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DisCussion
This is the first study to assess the impact of a deep neuromuscular block (PTC 1-2 
twitches) on surgical working conditions. The main results of our study are: (1) A deep 
neuromuscular block (TOF count = 0 and PTC 1-2 twitches) is associated with higher (i.e. 
improved) ratings from the surgeon compared to a moderate neuromuscular block (TOF 
count of 1-2 twitches) during laparoscopic prostatectomies and nephrectomies, indicat-
ing a significant improvement of surgical conditions; (2) Ratings from anaesthetists and 
surgeon of video images of the surgical field showed little agreement. In the current 
study, we chose to study retroperitoneal laparoscopic surgeries for two urological pro-
cedures (prostatectomy and (partial) nephrectomy) as these procedures are confined to 
a narrow working space where adequate (deep) muscle relaxation is of high importance 
and an effect of less optimal muscle relaxation on the quality of the surgical field is 
rapidly apparent. 
The leiden -  surgical rating scale 
The 5-point rating scale used in our study was developed in close cooperation with the 
surgeon involved in our project, who has ample experience in the performed procedures. 
It was decided that,  while the scoring system should integrate all qualitative aspects that 
are important to the surgeon when judging the surgical working field, it should remain 
as simple as possible. A scoring system with more than 5 points was initially considered, 
such as an 11-point numerical quantitative scale (for example, numerical rating or visual 
analogue scales from 0 to 10, cf. Ref. 9), however, it was decided to rank the surgical 
field qualitatively from extremely poor, via poor, acceptable, good to optimal conditions 
(see Table 1 for an explanation of the different ratings). Further, to reduce variability in 
scoring between assessors just one surgeon was requested to score the surgical field 
in our study. Our system is similar to other scoring systems. For example, the Clinical 
Global Impression (CGI) rating scale is a 7-point qualitative scale in which physicians rate 
the severity of a patient’s mental illness relative to the physician’s past experience.11 The 
GCI and our scoring systems are subjective but in our case the ample experience of the 
surgeon gives credibility to the procedure. Indeed the results of our study indicate that 
the surgeon was able to discriminate between a moderate and a deep neuromuscular 
block. The difference of 0.7 points (a difference of 18%) was regarded as important and 
clinically significant by the surgical team. We argue that the ability of our scoring system 
to discriminate between two distinct anaesthetic regimes indicates the validity of the 
5-point surgical rating scale we developed. 
Our study should be considered a proof-of-concept trial and further validation of the 
surgical rating scale is mandatory. Therefore, one should be cautious in extrapolation of 
our results to other procedures and other surgeons. Other surgeons may rate the surgi-
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cal condition differently and other procedures may require a different anaesthetic and/
or surgical approach. In an attempt to get an indication of the ability of other surgeons 
with ample experience in laparoscopic surgery to apply the scoring system, we invited 
eight surgeons, specialized in laparoscopic surgery for gastroenterological procedures, 
to score the 10 videos earlier presented to the anaesthetists. Their kappa statistic was 
on average 0.50 indicative of moderate agreement. As expected this agreement is 
substantially greater than that between surgeon and anaesthetists. It further shows 
that different surgeons (in this case with a different subspecialty) rate the surgical field 
differently. The current study was specifically aimed at scoring urological procedures 
performed in narrow retroperitoneal space. The results show a clinically relevant benefit 
of deep neuromuscular block for the surgeon involved in this study. Whether this benefit 
will also be relevant to other surgeons performing similar surgeries and possibly even 
for other laparoscopic procedures, such as for bariatric laparoscopic surgery is the topic 
of further research.
Deep neuromuscular block
Our a priori estimation of SRS distributions was satisfactory for the deep neuromuscular 
block but was underestimated for the moderate block. Good and optimal conditions 
were achieved during standard care (good 48% and optimal 34%) although at a lower 
frequency than during deep NMB (good 32% and optimal 67%). This indicates that in 82% 
of measurements during standard care and in 99% during deep NMB conditions were 
good to optimal. However, variability in ratings was high for moderate NMB compared 
to deep NMB: 26%, versus 5%. Also, in the deep NMB group, the range of scores (mean 
ranged from 4 to 5) was considered high and is still open for improvement. Further im-
provement may be obtained by (more) strictly controlling anaesthetic depth, analgesic 
state and arterial carbon dioxide concentrations. In the current study respirator settings 
were such that end-tidal carbon dioxide concentrations were between 4.4 and 6 kPa (33 
and 56 mmHg). High arterial carbon dioxide concentrations stimulate the respiratory 
neuronal pool in the brainstem, which activates the phrenic nerve.12 As a consequence, 
diaphragm contractions may persist despite a deep NMB. The neuromuscular block at 
the diaphragm is less intense than at the adductor pollicis muscle.13, 14 Indeed, some 
of the video images showed movement related to diaphragm contraction unrelated to 
the ventilator-induced inspiration-expiration sequence or cardiac contractions despite 
train-of-four values of zero. The surgeon scored such conditions at the low end of the L - 
SRS. In laparoscopic bariatric surgery the working space volume and visibility increased 
in response to neuromuscular blockade.15 In the current study, the retroperitoneal 
pressure was kept constant to 1.3-1.5 kPa (9-11 mmHg) in both groups and it may be 
assumed that the working space volume was greater in the deep NMB group. However, 
the scoring by the surgeon is only in part based on the perceived volume of the retro-
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peritoneal space. Other factors similarly influence the surgeon’s working conditions and 
consequently play an additional role in his scoring. For example, muscle contractions 
(including the diaphragm) and resultant movement of other structures are important as 
well. Further studies should address these issues. 
We tested deep versus moderate block using two different drug regimens. The reason 
for this was that this approach enabled us to compare our current practice with atracu-
rium and mivacurium with an approach that not only allows us to induce a deep neu-
romuscular block but also allows rapid reversal of that deep block. Since our end-point 
was to compare the depth of the neuromuscular block irrespective of the drugs used to 
induce that state, we do not believe that this influenced our outcome significantly. We 
observed that full reversal after deep NMB occurred after 5 min. It is importantto realise 
that measurements were made at 5-min intervals and full reversal with TOF ratio’s > 0.9 
may have occurred earlier (for sugammadex reversal to TOF ratio > 0.9 is expected after 
2-3 min).
scoring by anaesthetists of the surgical field
An important finding in our study is that the agreement of scores between the anaes-
thetists and surgeon was poor. This indicates that the anaesthetists are less well able 
to measure the quality of surgical conditions from the video images and hence derive 
insufficient information from these images regarding the working conditions of the 
surgeon. It may be argued that in our study observing a 30-s video image does not pro-
vide sufficient input to assess the quality of surgical condition in non-surgically skilled 
personnel. This may be true, but in our study, and possibly also in clinical practice, the 
anaesthetists base their impression of the surgical field primarily on the volume of the 
working space and the visibility of retroperitoneal tissues (most importantly related to 
the absence or presence of blood in the image obscuring relevant structures) without 
addressing muscle contractions and other movements visible on the video image. In 
our hospital, life video images of the laparoscopic field are available to the anaesthetists 
during each case and these, together with his/her clinical experience and interaction 
with the surgeon, form the basis of the anaesthetic regimen, including the additional 
use of muscle relaxants when surgical conditions are deemed poor. Some anaesthetists 
may not be willing to induce a deep neuromuscular block. This may be related to their 
inability to adequately judge the operating field from the video screen or to their fear 
for suboptimal post-surgical conditions. This may be the cause of some discussion in the 
operating room. To prevent such situations, we suggest that surgeons and anaesthetists 
communicate their wishes and intentions prior to the procedure (e.g. during preopera-
tive time-out) and closely cooperate in obtaining optimal working conditions. Here we 
show that providing a deep neuromuscular block improves surgical conditions.  
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Chapter 3
Influence of variations in arterial 
pCO2 on evaluation of surgical 
conditions during laparoscopic 
surgery 
Martijn Boon, Christian Martini, Marieke Hellinga, Rob Bevers, Leon 
Aarts, Albert Dahan




Although deep neuromuscular block (post-tetanic-count 1-2 twitches) improves surgical 
conditions during laparoscopic retroperitoneal surgery compared to a standard block 
(train-of-four 1-2 twitches), the quality of surgical conditions varies widely, possibly 
related to diaphragmatic contractions. Hypocapnia may improve surgical conditions by 
silencing the diaphragm. In this study we assessed the effect of changes in arterial car-
bon dioxide concentrations on surgical conditions in patients undergoing laparoscopic 
surgery under general anaesthesia and deep neuromuscular block.
methods 
Forty patients undergoing elective laparoscopic surgery for prostatectomy or nephrec-
tomy received propofol/ remifentanil anaesthesia and a deep neuromuscular block with 
rocuronium. Patients were randomized to surgery under hypocapnic or hypercapnic 
conditions. During surgery, the surgical conditions were evaluated using the 5-point 
Leiden- surgical rating scale (L-SRS) ranging from 1 (extremely poor conditions) to 5 
(optimal conditions) by the surgeon, who was blinded for the randomization allocation.
results 
Mean (SD) arterial carbon dioxide concentrations were 4.5 (0.6) kPa under hypocapnic 
and 6.9 (0.6) kPa under hypercapnic conditions. The L-SRS did not differ between groups: 
4.84 (0.4) in hypocapnia and 4.77 (0.4) in hypercapnia. Ninety-nine percent of ratings 
were good or optimal irrespective of the treatment.
Conclusions 
Deep neuromuscular block provides good to optimal surgical conditions in laparoscopic 
retroperitoneal urological surgery, independent of the level of arterial pCO2.
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inTroDuCTion
Anaesthetists play an essential role in optimizing surgical conditions. This is especially 
true for procedures which are performed in a narrow space, such as laparoscopic retro-
peritoneal surgery and robot-assisted laparoscopic surgery.1, 2 We recently showed that 
application of a deep neuromuscular block (deep NMB, 1-2 twitches post- tetanic- count) 
significantly improves surgical conditions in laparoscopic retroperitoneal prostatecto-
mies and nephrectomies and greatly reduces the incidence of unacceptable conditions.1 
Similar observations were made by others for laparoscopic gynaecological procedures 
and laryngeal microsurgery.3, 4 Despite the improvement of surgical conditions at deep 
muscle relaxation, the variation in surgical conditions is still high (>20%), indicating that 
there is still room for improvement.1 Also other studies show that that during deep NMB 
suboptimal surgical conditions may persist. For example, Fernando et al. showed that 
at deep NMB (PTC values 1-2 twitches) diaphragmatic contractions still occur.5 Causes 
of such diaphragmatic contractions include resistance to muscle relaxants (diaphragm 
relaxation is often less intense compared to relaxation of the adductor pollicis longus 
muscle) as well as efferent activation from brainstem respiratory centres due to high ar-
terial CO2 levels. The latter item is relevant as CO2-insufflation with high intra-abdominal 
pressures during laparoscopic surgery coincides with high arterial CO2 concentrations 
even when end-tidal concentrations suggest values in the normal range.
One possible method to reduce high CO2-related diaphragm contractions is to hyper-
ventilate the patient to (sub)normal arterial pCO2 levels. Application of this technique 
has been used before to reduce the dose of anaesthetics and to improve surgical condi-
tions when standard relaxation is applied (TOF 1-2 twitches).6-8 Here we study the effect 
of hyperventilation to assess whether we can further improve surgical conditions during 
deep neuromuscular relaxation. We hypothesize that the induction of hypocapnia dur-
ing laparoscopic surgery improves surgical conditions compared to hypercapnia.
meThoDs
The study with acronym BLISS2 was carried out at Leiden University Medical Centre be-
tween February 2013 and September 2015 after approval was obtained of the protocol 
(protocol number P13.127) by the local medical ethics committee (Commissie Medische 
Ethiek). The protocol was registered at clinicaltrials.gov under number NCT01968447. 
The study was conducted in accordance with Good Clinical Practice and Good Research 
Practice guidelines. Eligible patients were approached in advance by one of the investi-
gators and received oral and written information about the study. If a patient was willing 
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and able to participate, oral and written informed consent was obtained. The study had 
a randomized (hypocapnia against hypercapnia), double-blinded design (the surgical 
team and the investigators were blinded to treatment allocation; the attending anaes-
thetist was not blinded). Randomisation was performed using a computer-generated 
randomization list obtained from www.randomization.com. The attending anaesthetist, 
who received the randomization code just prior to induction of anaesthesia, was re-
sponsible for setting the desired tidal volume and respiratory rate on the anaesthesia 
ventilator (Primus, Dräger Medical Netherlands BV, Zoetermeer, the Netherlands). 
American Society of Anesthesiologists (ASA) class I-III patients were included if they 
had prostatic or renal disease requiring elective laparoscopic retroperitoneal surgery. 
Patients were excluded if they were < 18 years of age, ASA class > III, had a known or sus-
pected neuromuscular disorder, allergies to medication to be used during anaesthesia, a 
(family) history of malignant hyperthermia, renal insufficiency (as defined by glomerular 
filtration rate of < 30 mL.h-1), previous retroperitoneal surgery at the site of the current 
surgery, a body mass index > 35 kg.m-2 or chronic obstructive pulmonary disease GOLD 
2 or higher.
Perioperative protocol
All patients received total intravenous anaesthesia with propofol, remifentanil and 
rocuronium; the patients inhaled 40% oxygen in nitrogen. Monitoring was according 
to local practice and consisted of ECG, blood pressure and EEG monitoring (BIS module, 
Philips, Eindhoven, the Netherlands). Throughout surgery BIS values were kept between 
45-55. A 22-gauge arterial cannula was placed in the radial artery of the left or right wrist 
and connected to a Vigileo advanced minimally invasive monitoring system (Edwards 
Lifesciences, USA) for hemodynamic monitoring. The arterial cannula was further used to 
obtain blood samples for arterial pCO2 measurements at 15 min intervals.
Neuromuscular monitoring was performed using the TOF cuff device (RGB Medical 
Devices, SA, Madrid, Spain).9 The TOF cuff is an upper arm cuff that was applied contra-
lateral to the blood pressure cuff.  The cuff incorporates two electrodes that stimulate 
the ulnar nerve. The evoked neuromuscular activity is recorded by measuring the 
pressure change induced by the muscular activity from stimulation. In comparison with 
mechanomyography (gold standard), the TOF cuff has an acceptable bias and limits of 
agreement, which compares to acceleromyography.9 In a few patients we compared 
the TOF cuff with the TOF watch and observed similar results. Hence, we contend that 
using the TOF cuff resulted in a reliable assessment of neuromuscular function during 
anaesthesia. The TOF cuff is easier to use in patients in the lateral position or when the 
arm is hidden below the surgical drapes. 
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The TOF cuff was calibrated after induction but before administration of rocuronium. 
Thereafter, rocuronium 1.0 mg.kg-1 was given and a continuous rocuronium infusion 
was started at 0.2-0.6 mg.kg-1.h-1. The depth of neuromuscular block was closely moni-
tored and aimed at 1-2 twitches post-tetanic count (PTC; i.e. a deep NMB). At the end 
of surgery, the deep NMB was reversed with a bolus dose of sugammadex 4 mg.kg-1. 
The patient was extubated when the TOF ratio was > 0.9 and the patient was breath-
ing spontaneously and opened his/her eyes on request. For postoperative pain relief, 
morphine 0.15-0.2 mg.kg-1 was given at least 45 min before surgical closure.  
All patients were randomized before induction of anaesthesia and the “time out” proce-
dure. Allocation to treatment was performed just prior to intra-abdominal insufflation 
of carbon dioxide. Patients were randomly assigned to one of two treatment groups. 
Group 1: hypocapnia during surgery (arterial pCO2 range 3.5 to 4.5 kPa or 26 to 34 
mmHg). The tidal volume of the ventilator was set at 7 mL.kg-1 and the respiratory rate 
at 16 min-1; Group 2: hypercapnia during surgery (arterial pCO2 range 6.5 to 7.5 kPa or 49 
to 53 mmHg). The tidal volume of the ventilator was set at 7 mL.kg-1 and the respiratory 
rate at 11 min-1. Insufflation rates were adjusted such that the target arterial pCO2 was 
maintained throughout the laparoscopic procedure. However, the attending anaesthe-
tist could deviate from the protocol at his/her discretion. In both treatment groups PEEP 
values were kept constant during anaesthesia at 5 mmHg. 
The leiden - surgical rating scale (l-srs)
During the laparoscopic procedure, the surgical field was rated by one surgeon (RB), 
with ample experience in laparoscopic retroperitoneal renal and prostatic surgery, using 
the Leiden - surgical rating scale (L-SRS).1 The L-SRS is a five-point scale, which covers 
the quality of the surgical field from extremely poor to optimal conditions (see Table 1 
in Ref. 1 for a detailed description of the L-SRS). If the rating was 3 or lower, the surgeon 
and anaesthesia team would negotiate ways to improve the surgical working field. For 
example, a bolus of rocuronium 15 mg could be given in case of suboptimal neuro-
muscular block and the infusion rate increased by 20% or propofol 30 mg in case of 
high BIS values. The L-SRS is currently used in multiple studies to assess the influence of 
anaesthesia on the surgical field in retroperitoneal, laparoscopic, thoraco-laparoscopic 
and microlaryngeal surgeries.1, 2, 10, 11 
sample size calculation
The primary end-point of this study is the L-SRS. Our previous study yielded a mean sur-
gical rating score of 4.7 during deep NMB. 1 However, in that study, arterial pCO2 was not 
controlled resulting in hypo- or hypercapnic conditions in some patients. Also, depth of 
anaesthesia was not controlled, possibly resulting in deep levels of anaesthesia (BIS < 
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40), which may have confounded the study outcome to some extent. A realistic a priori 
estimation of the L-SRS in the current study was 4.1-4.3 in the hypercapnic group and 
4.8-4.9 in the hypocapnia group. The estimated mean difference between the treatment 
groups was therefore conservatively estimated to be 0.5. Assuming a standard deviation 
of 0.45, a sample size of at least 19 subjects would provide at least 90% power to observe 
the expected difference at alpha = 0.05. 
Data and statistical analysis
The following clinical variables were collected on the case record form: surgical variables 
(L-SRS, retroperitoneal pressure), anaesthesia variables (BIS, TOF or PTC, drug dosages), 
hemodynamic variables (arterial blood pressure, heart rate, cardiac index) and respira-
tory variables (arterial and end-tidal pCO2, tidal volume, respiratory rate, inspiratory 
pressure, PEEP). Repeated measurements were made at 15 min intervals. 
Data analysis was based on an intent-to-treat basis. A linear mixed model with an 
autoregressive covariance structure was used to determine the effect of hypocapnia 
against hypercapnia on the primary end-point, L-SRS. Secondary end-points were the 
effect of hypocapnia against hypercapnia on cardiorespiratory variables. These variables 
were averaged over time to get an indication of their mean value. Treatment effects were 
evaluated on the average data by t-test. The data were analyzed with SPSS (v. 22; IBM 
corporation, Armonk, NY, USA0). All data are presented as mean ± SD unless otherwise 
stated. p-values < 0.05 were considered significant. 
resulTs
The flow chart of the study is given in Figure 1. After randomization, three randomized 
patients were not studied due to inability to insert an arterial line (n = 2) and a deci-
sion to perform open surgery at the pre-surgical “time-out”. These three patients were 
replaced. In total 40 patients in both groups received the allocated treatment and were 
analyzed. Patient characteristics and data obtained at screening did not differ between 
groups (Table 1). 
anaesthesia, pCo2 and neuromuscular blockade
The use of anaesthetics and opioids did not differ between groups. Also, post-tetanic-
count values were comparable (3.2 - 3.8), indicative of a similar deep NMB in both treat-
ment groups (Table 2). Figs. 2A and B show the individual profiles of the end-tidal pCO2 
over time for the two study groups and the individual mean end-tidal and arterial pCO2 
values. The end-tidal pCO2 differed by 2.3 kPa between treatments: hypocapnia 3.4 (0.2) 
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Allocated to group 2:
n=20
Allocated to group 1:
n=20
Analyzed: n=20 Analyzed: n=20
Not meeting inclusion criteria: n=2
Declined participation:                 n=4
No arterial line inserted: n=2
Immediate conversion to open: n=1
figure 1. Study flow chart






Prostate surgery (n) 13 11
Renal surgery (n) 7 9
ASA class I (n) 8 3
ASA class II (n) 12 17
Gender M/F (n/n) 17/3 14/6
Age (years; median, range) 65 (22-80) 62 (25-72)
Weight (kg) 81 (12) 81 (17)
Height (cm) 176 (10) 175 (9)
BMI (kg.m-2) 26,1 (3.4) 26.3 (4.3)
BP systolic (mmHg) 137 (15) 139 (16)
BP diastolic (mmHg) 81 (11) 85 (12)
Heart rate (min-1) 77 (16) 74 (14)
Data are presented as mean (SD) unless stated otherwise.
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kPa with a range of 3.0 to 3.7 kPa and hypercapnia 5.7 (0.5) kPa with a range of 4.9 to 
6.8 kPa. Similarly, arterial pCO2 differed by 2.4 kPa between treatments: hypocapnia 4.5 
(0.6) kPa (range 3.8-5.6 kPa) and hypercapnia 6.9 (0.6) kPa (range 6.1 – 8.1 kPa). A clear 
difference between arterial and end-tidal pCO2 was present during both hypocapnia 
and hypercapnia and averaged to 1.2 (0.1) kPa (Fig. 2). As is visible in panels C and D of 
Figure 2, the difference tended to slowly increase over time. 
rating of surgical conditions
We obtained 9 to 12 scores per patient. In Figure 3A, the mean scores over time are given 
for the two treatment groups. The scores did not differ between groups (p = 0.59). The 
mean of the mean L-SRS scores were: hypocapnia group 4.84 (0.4) against hypercapnia 
group 4.77 (0.4) (Fig. 3B). The distribution of the individual L-SRS scores is given in Figure 
3C, showing that 99% of all scores were good or optimal, irrespective of the arterial pCO2 
conditions. There was no correlation between end-tidal pCO2 and L-SRS (Fig. 3D, Pearson 
r = 0.02, p = 0.9) or between arterial pCO2 and L-SRS (r = -0.08, p = 0.67). 
Table 2. Measurements during anaesthesia and surgery. 
  hypocapnia hypercapnia
Duration (min) 184 (43) 170 (50)
BIS 41 (3) 43 (5)
Propofol (g) 1.7 (0.4) 1.5 (0.5)
Remifentanil (μg.kg-1.min-1) 0.21 (0.06) 0.19 (0.08)
Rocuronium (mg) 223 (65) 201 (94)
Sugammadex (mg) 317 (77) 334 (96)
Post-tetanic-count 3.2 (2.4) 3.8 (3.3)
Retroperitoneal pressure (mmHg) 11 (1) 11 (1)
Leiden – surgical rating scale 4.84 (0.4) 4.77 (0.4)*
Mean arterial pressure (mmHg) 85 (10) 81 (9)
Heartrate (min-1) 68 (11) 69 (9)
Cardiac output (L.min-1) 3.9 (1.1) 4.4 (1.3)
Arterial pCO2 (kPa) 4.5 (0.6) 6.9 (0.6)**
Arterial pCO2 range (kPa) 3.8-5.6 6.1-8.1
End tidal CO2 (kPa) 3.4 (0.2) 5.7 (0.5)**
Minute volume (L.min-1) 12.5 (2.1) 7.1 (1.3)**
Respiratory rate (min-1) 20.3 (3.0) 12.7 (1.6)**
Inspiratory pressure (cm H20) 25 (4) 22 (2)*
Peep (cm H20) 5 (0.6) 5 (0.3)
Values are mean (SD). * p>0.05, **p<0.001
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measurements following surgery
NMB reversal was by sugammadex 4 mg.kg-1 and resulted in optimal extubation condi-
tions (train-of-four ratio > 0.9) within 3 min in all patients. Postoperative pain scores 
were similar between groups (data not shown).  
DisCussion
We tested the hypothesis that hypocapnia would improve surgical conditions during 
retroperitoneal laparoscopic surgery and deep muscle relaxation, as rated by the Leiden-
surgical rating scale To emphasize any difference between the treatment groups, we 
compared hypocapnic conditions against hypercapnic (rather than normocapnic) con-
ditions induced by differences in respiratory rate. We cannot reject the null-hypothesis 
as no differences were observed in L-SRS (mean L-SRS hypocapnia 4.84, hypercapnia 
4.77; Figs. 3A-D) between the two CO2 conditions. 
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∆
figure 2. a. Individual end-tidal pCO2 values over time. Blue lines hypocapnia, orange lines hypercapnia. b. 
Individual mean end-tidal and arterial pCO2 values and mean of the means (SD). * p < 0.001. C and D. Pro-
files of the arterial pCO2, end-tidal pCO2 and difference between arterial and end-tidal pCO2 (ΔpCO2) under 
hypocapnic (C) and hypercapnic conditions (D). Data are mean ± 95% confidence interval. 
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There are many physiological and pharmacological effects of hypocapnia that made 
us believe that lowered arterial CO2 concentrations would improve surgical conditions. 
These effects include deepening of the anaesthetic state, enhanced muscle relaxation, 
inhibition of and abdominal muscle reflexes and a reduced efferent output from the 
brainstem to the diaphragm.6-8, 12 Our inability to detect a significant difference between 
L-SRS scores does not imply that any of these effects of hypocapnia did not occur. It 
simply indicates that hypocapnia, irrespective of the physiological changes it causes, 
was without effect on the quality of the surgical field. We infer from our data that in case 












































A.   B.
C.   D.
Hypocapnia
Hypercapnia
figure 3. a. Mean (95% confidence interval) Leiden - surgical rating scale (L - SRS) scores versus time un-
der hypocapnic (blue symbols) and hypercapnic conditions (orange symbols). b. Individual mean L - SRS 
scores (each symbol is the mean L - SRS of one patient) and mean of the means (SD). In green the results 
of the patients that had recieved a deep NMB (under normocapnic conditions) in the BLISS 1 study.  C. 
Distribution of the surgical ratings under hypocapnic (blue bars) and hypercapnic (orange bars) conditions. 
D. Individual mean L - SRS scores versus mean individual end-tidal pCO2 values in subjects treated with 
hypocapnia (blue symbol) and hypercapnia (orange symbol). Pearson r = 0.02, p = 0.9. 
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of suboptimal surgical conditions, increasing ventilation is without effect and additional 
relaxation may be required.
We induced hypocapnia by increasing respiratory rates rather than increasing tidal 
volume. We did not allow high tidal volumes to prevent any pressure-related damage 
to the lungs.13 Despite the relative high insufflation rates in hypocapnia peak inspiratory 
pressures were considered acceptable (Table 2) and none of the patients experienced 
any harm from the hypocapnic treatment. 
Two recent studies from outside our institute have been published that use the L-SRS 
to assess the quality of the surgical field in deep NMB. Yoo and colleagues2 observed 
a mean score of 4 (range 3-5) during deep NMB against a mean score of 3 (range 2-5) 
during a moderate block in robotic laparoscopic prostate surgery. Kim and colleagues4 
showed improved conditions during deep block compared to a moderate block in micro 
laryngeal surgery with 92% of patients with scores 4 or 5 at PTC 1-2 and 78% at TOF 1-2. 
Furthermore, just 3% of patients at deep NMB exhibited vocal cord movement during 
surgery compared to 39% of patients at moderate NMB. These studies indicate not only 
that a deep NMB is associated with superior surgical conditions in various complex 
surgeries but also show the practical usefulness of the L-SRS in scoring the quality of 
surgical field in different surgeries. Screening the various public clinical trial registries 
showed that additional studies that assess surgical conditions during anaesthesia us-
ing the L-SRS are underway, including one study on the effect of deep NMB in bariatric 
surgery (clinicaltrials.gov identifier NCT02553629). Apart from the 5-point L-SRS that we 
developed, other scoring systems were used in clinical studies, such as a 4-point scale by 
Dubois et al.3 with similar end-points to those we used, a 4-point scale to assess the sur-
gical space conditions by Staehr-Rye et al.14 (only the worst score per case is reported), 
and a 100-point visual analogue scale by Blobner et al.15 While we do not feel that one 
scoring system is superior to the other, we do express the need for a uniform scoring 
system that allows comparison between studies. 
There are some limitations to our study. (1) The target pCO2 at hypocapnia was not 
reached in all patients. Hyperventilation to relatively low levels of pCO2 is more difficult 
in laparoscopic surgeries with continuous intracorporal CO2 insufflation than in open 
surgeries. Greater ventilatory frequencies than applied would have been required 
to reach the target values. Since these high rates often hindered the surgeon we ac-
cept these deviations from target. (2) Scoring in our current and previous study was 
performed by one surgeon (RB), with large experience in the tested surgeries. This elimi-
nates inter-observer variability but other surgeons may rate the surgical field differently, 
especially surgeons with less experience or surgeons trained in other subspecialties. 
This is illustrated by our previous observation that there was just moderate agreement 
between the ratings of our expert surgeon and eight other laparoscopy-skilled surgeons 
who rated video images of the surgical procedure.1 Further validation of the L-SRS in 
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other specialties is therefore necessary. (3) The ability to effectively reverse a deep NMB 
in an acceptable time frame is essential in clinical practice. Sugammadex is currently 
the only reversal agent that allows rapid and safe recovery from a deep block without 
consequences such as residual curarization. However, the restricted use or availability of 
sugammadex in some hospitals makes application of a deep NMB not always practical. 
In conclusion, our study shows that deep NMB provides good to optimal surgical 
conditions in laparoscopic retroperitoneal urological surgery, which were independent 
of the level of arterial pCO2.
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absTraCT
background 
Recent data shows that a neuromuscular block (NMB) induced by administration of high 
doses of rocuronium improves surgical conditions in certain procedures. However, there 
are limited data on the effect of such practices on postoperative outcomes. 
methods 
A retrospective analysis was conducted to compare unplanned postoperative 30-day 
readmissions in patients that received high-dose versus low-dose rocuronium admin-
istration during general anaesthesia for laparoscopic retroperitoneal surgery. Charts 
of patients receiving anaesthesia between January 2014 and December 2016 were 
searched for surgical cases receiving high-dose rocuronium and matched with respect 
to procedure, age, sex and ASA classification to patients receiving low-dose rocuronium. 
The primary postoperative outcome was the unplanned 30-day readmission rate. 
results 
Each cohort contained 130 patients. Patients in the high-dose and low-dose rocuronium 
cohorts received 217 ± 49 versus 37 ± 5 mg rocuronium, respectively. All patients receiv-
ing high-dose rocuronium were reversed with sugammadex, while just 33% of matched 
patients were reversed with sugammadex and 20% with neostigmine; the remaining 
patients were not reversed. Unplanned 30-day readmission rate was significantly lower 
in the high-dose compared to the low-dose rocuronium cohort (3.8% vs. 12.7%; p = 0.03; 
odds ratio = 0.33, 95% C.I. 0.12-0.95). 
Conclusion 
This small retrospective study demonstrates a lower incidence of unplanned readmis-
sions within 30-days following laparoscopic retroperitoneal surgery with high-dose 
relaxant anaesthesia and sugammadex reversal in comparison to low-dose relaxant 
anaesthesia. Further prospective studies are needed in larger samples to corroborate 
our findings and additionally assess the pharmaco-economics of high-dose relaxant 
anaesthesia taking into account the benefits (reduced readmissions) and harm (costs of 
relaxants and reversal agents) of such practice. 
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inTroDuCTion
Typically, general anaesthesia is induced by administration of a hypnotic agent to 
provide loss of consciousness, an opioid analgesic to blunt hemodynamic and stress 
responses and a muscle relaxant to facilitate tracheal intubation and improve surgical 
conditions.1, 2 Recently we showed that a neuromuscular block (NMB) induced by the 
administration of high-dose rocuronium, produces superior surgical conditions com-
pared to the traditionally used NMB induced by low-dose rocuronium in laparoscopic 
retroperitoneal urologic and bariatric surgery.3, 4 This has been replicated by others in 
various abdominal and non-abdominal procedures.5-9 Moreover, a high-dose rocuronium 
NMB effectively precludes unexpected deterioration of the surgical field at any time.3-9 
Prevention of sudden patient movements is important during critical procedures, such 
as ophthalmic and neuro-radiologic intervention procedures. Additionally, recent data 
suggest that high-dose rocuronium NMB may improve pain scores after laparoscopic 
surgery,4 although this is not a consistent finding.3, 10 
Although tightly controlled randomized trials have shown improved subjective scores 
of surgical conditions when using high-dose rocuronium NMB, there is little evidence 
that the use of a high-dose rocuronium NMB improves outcome such as reduced post-
operative pain scores or less postoperative surgical complications. In addition, the use 
of muscle relaxants during anaesthesia is associated with postoperative residual neuro-
muscular blockade and respiratory complications.11, 12 Therefore, the intraoperative ben-
efits of high-dose rocuronium NMB during surgery must be weighed against possible 
postoperative complications. Currently, one possible strategy to prevent residual NMB 
induced by high-dose rocuronium NMB is reversal with sugammadex, a rocuronium- and 
vecuronium-specific reversal agent that has been associated in previous studies with a 
reduction in the incidence of postoperative respiratory complications.13, 14 However, the 
cost of sugammadex is a consideration and the cost benefit of high-dose rocuronium 
NMB has therefore been questioned due to its uncertain effect on outcomes and the 
high cost of reversal.15 
Given the results of the majority of studies showing improved surgical conditions during 
high-dose rocuronium NMB, we have routinely applied such a NMB in close coordina-
tion with our surgical colleagues since July 2015. The high-dose rocuronium NMB is now 
a part of our clinical practice in a variety of surgical procedures including laparoscopic 
abdominal procedures, eye surgery and neuro-radiological interventions. To under-
stand the utility of high-dose rocuronium anaesthesia under “real world” conditions and 
to address the above-mentioned gap in the evidence on outcomes, we performed a 
retrospective analysis of chart data to compare high-dose versus low-dose rocuronium 
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administration in patients undergoing laparoscopic retroperitoneal surgery. In the 
analysis we focused on unplanned 30-day readmission rates. Unplanned 30-day read-
mission is a quality measure of patient care and is costly.16-18 Previous studies showed 
that an important factor associated with unplanned readmission is surgical complexity, 
with infectious complications being the most common indication for readmission.16, 19-21 
We hypothesized that the intraoperative advantage created by high-dose rocuronium 
(i.e. high-dose rocuronium NMB) may ultimately translate into fewer unplanned read-
missions within the 30 days following the elective surgical procedures. The choice of 
focusing on laparoscopic retroperitoneal surgery is based on the fact that in our institu-
tion the majority of general anaesthetics with high-dose relaxant is applied for these 
procedures as they benefit the most from high-dose rocuronium NMB compared to 
other laparoscopic procedures.3
meThoDs
High-dose rocuronium NMB was applied using a standard operating procedure that was 
introduced in July 2015 in our hospital for a series of procedures unless contraindicated 
(e.g. allergies to rocuronium or sugammadex, an estimated glomerular filtration rate < 
30 mL.kg-1). High-dose rocuronium NMB is induced by an induction dose of rocuronium 
(1 mg.kg-1), followed by a continuous infusion (range 20-50 mg.h-1) aimed at a post-
tetanic count of 1-2 twitches as measured by the TOF cuff monitor system (RGB medical 
devices, Madrid, Spain). After approval of the protocol by the local institutional ethical-
board (Commissie Medische Ethiek, Leiden University Medical Center, 2300 RC Leiden, 
the Netherlands) and registration at clinicaltrials.gov (NCT03174223), fully anonymized 
data of patients that received anaesthesia from January 2014 to December 2016 were 
retrieved from two electronic medical record databases (Healthcare Information X-
change (HIX) and Patient Data Management System (PDMS) both from Chipsoft, the 
Netherlands). The electronic databases were searched for cases that received general 
anaesthesia with high-dose rocuronium by continuous infusion for any type of elec-
tive procedure by using HIX and PDMS specific queries. High-dose rocuronium was 
defined by a 1 mg.kg-1 bolus dose at induction followed by a continuous infusion. Next, 
we identified cases that received high-dose rocuronium from July 2015 to December 
2016 were matched (one-on-one) for type of surgery, sex, age and American Society 
of Anesthesiologists (ASA) physical status classification to a case that had received 
general anaesthesia with low-dose rocuronium from January 2014 to July 2015.  Low-
dose rocuronium was defined by a 0.6 mg.kg-1 bolus dose at induction and absence of 
a continuous infusion during the surgical procedure. The matching was performed on 
type of surgery, sex, age (ages could differ by a maximum of 4 years) and ASA status (ASA 
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class 1 and 2 were combined into one group). The research team checked and validated 
the data manually for consistency and accuracy.
The following data  were compared between patients that had received high- and low 
dose rocuronium NMB: (1) patient-related data, including age, sex, weight, body mass 
index (BMI) and ASA physical status classification; (2) data related to anaesthesia and 
surgery, including surgery type, hemodynamics (blood pressure and heart rate; average 
of values collected during surgery), depth of anaesthesia as measured by bi-spectral 
index monitoring (average of values collected during surgery), drugs administered and 
their dose, duration of surgery, duration of anaesthesia, postoperative pain scores (mea-
sured on an 11-point verbal rating scale (VRS) from 0, no pain to 10, worst imaginable 
pain); (3) immediate respiratory complications as defined by hypoxemic events in the 
PACU (SpO2 < 90%), bronchospasm, pneumonia during hospital stay; (4) admissions to 
intensive or intermediate care departments during hospital stay; (4) 30-day unplanned 
readmission data (cause of readmission, duration of readmission and relevant patient 
data of readmitted cases); (5) cost of relaxation and reversal. Pain scores were obtained 
in the post-anaesthesia care unit (PACU) at 15 min intervals and on the ward three-times 
daily. The pain data were averaged for location (i.e. average pain data obtained at the 
PACU and on the ward). 
Data were analyzed comparing high-dose relaxant versus low-dose relaxant groups by 
paired-t-test, Mann-Whitney U test or χ2 test, depending on the type of data and data 
distribution. Data are presented as mean ± SD or median with interquartile range (IQR); 
p-values < 0.05 were considered significant. Data analysis was performed using Graph-
Pad Prism version 7.00 for MAC OS X (GraphPad Software, La Jolla, CA).
The primary outcome of our study was the incidence of unplanned readmission within 
30-days of the elective surgical procedure; secondary outcome was cost of relaxation 
and reversal in the high- and low-dose rocuronium cohorts. Additionally, we compared 
duration of surgery and anaesthesia, and postoperative pain between cohorts. 
resulTs
Patients and procedures
During the search period 51,000 anaesthetics were administered for various procedures 
at Leiden University Medical Center. The initial selection procedure resulted in 537 
cases that were considered eligible for inclusion in the analysis. High-dose rocuronium 
anaesthesia was administered most frequently to patients undergoing urological 
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procedures, ophthalmologic surgery or surgical renal procedures. During the manual 
validation process 407 cases were excluded for the following reasons: age < 18 years, 
lack of surgical procedure code, multiple patient inputs, missing time stamps, absence 
of reversal dosing information, or procedures other than elective laparoscopic retroperi-
toneal surgeries (these procedures included open eye surgeries (n = 77), gastrointestinal 
surgery (n = 14), organ transplantations (n = 15), neurosurgical procedures (n = 4) and 
gynaecological procedures (n = 1)). The final data set consisted of 130 cases that received 
high-dose rocuronium in patients undergoing elective laparoscopic retroperitoneal 
surgery. Matching was successful in 100% of cases, yielding a total of 130 cases that on 
average received 217 ± 49 mg rocuronium and 130 matched cases that received 37 ± 
5 mg rocuronium. Patient characteristics and surgical procedures are given in Table 1. 
Patients in the two cohorts had similar age, ASA classification, weight and body mass 
index. Due to the predominance of urology in our cohort, males were in the majority (in 
each cohort 98 men and 32 women). Glomerular filtration rate was above 30 mL.min-1 







Number of patients (n) 130 130
Men/women (n/n) 98/32 98/32
Age (years; mean, 95% CI) 60 (58-63) 59 (56-61) 0.46
Weight (kg; median, IQR) 81 (73-92) 80 (72-93) 0.65
BMI (kg.m-2; median, IQR) 26 (24-29) 25 (23-29) 0.21
ASA score 1 34% 32%
ASA score 2 60% 62%
ASA score 3 6% 6%
ASA score 4 0% 0%
ASA score 5 0% 0%
CKD stage 1-3 (n) 130 125
CKD stage 4 and 5 (n) 0 5
 laparoscopic retroperitoneal procedures (n)
Nephrectomy (partial + complete) 56 56
Retroperitoneal lymph node resection 36 36
Prostatectomy 24 24
Pyelumplasty 14 14
CKD = chronic kidney disease. CKD stage 1-3: glomerular filtration rate ≥ 30 mL/min; CKD stage 4 and 5; 
glomerular filtration rate < 30 mL/min. Values are numbers (n), percentages or mean and 95% confidence 
interval (95% CI) or median and interquartile range (IQR).
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in all patients receiving high-dose rocuronium and in 125 patients receiving low-dose 
rocuronium.
anaesthesia and surgery
The two study cohorts differed by a factor of 6 in the amount of rocuronium that was 
administered (Table 2; Supplemental Figure 1). For induction and maintenance all pa-
tients received propofol combined with remifentanil, sufentanil or both. More patients 
in the high-dose relaxant group received remifentanil (65% vs. 33%) with on average a 
20% higher dose compared to patients in the low-dose relaxant group (p = 0.015, Table 
2). Similarly, patients that received sufentanil in the high-dose relaxant groups received 
on average a 14% higher dose than patients in the low-dose relaxant group (p = 0.025, 
Table 2). 
All patients in the study received rocuronium as muscle relaxant. Patients that received 
high-dose rocuronium were all reversed with sugammadex (dose 267 ± 101 mg), while 
patients in the low-dose rocuronium group were either not reversed (46%), received su-
gammadex (34%, dose 212 ± 55 mg, p < 0.001 vs. high-dose relaxant group) or received 
neostigmine (20%, dose 1.4 ± 0.6 mg). Duration of anaesthesia, duration of surgery and 
heart rate values did not differ between cohorts. A small difference in bi-spectral index 
(BIS) values was observed with a deeper anaesthesia level in patients receiving high-
dose than low-dose rocuronium. However, the difference was small (mean difference = 
1.5 with 95% confidence interval 0.1-3.0, p = 0.03). Similarly, a small difference in mean 






Total intravenous anaesthesia (n) 130 130
Propofol dose (mg.kg-1.min-1) 0.13 (0.06) 0.13 (0.05) 0.62
Remifentanil (n) 71 33
Remifentanil dose (μg.kg-1.min-1) 0.16 (0.05) 0.13 (0.04) < 0.001
Sufentanil (n) 87 108
Sufentanil dose (μg.kg-1) 1.5 (0.8) 1.3 (0.6) 0.025
Rocuronium dose (mg) 217 (49) 37 (5) < 0.001
Sugammadex (n) 130 44
Sugammadex dose (mg) 267 (101) 212 (55) < 0.001
Neostigmine (n) - 26
Neostigmine dose (mg) - 1.4 (0.6)
Atropine (n) - 26
Atropine dose (mg) - 0.6 (0.2)
Values are number of patients (n) or mean (SD).
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arterial pressure was observed between groups (mean difference 5.5 mmHg with 95% 
confidence interval 3-8 mmHg, p < 0.01). See Tables 2 and 3.
There were no differences in postoperative pain between the two groups in the PACU 
(median verbal rating scale high-dose relaxant: 3.0, IQR 1.0-4.7 vs. low-dose relaxant: 
2.7, IQR 1.0-4.0; p = 0.19) and the ward (median VRS high-dose relaxant: 2.0, IQR 1.0-3.3 
vs. low-dose relaxant: 2.0, IQR 1.1-3.1 p = 0.89). Length of hospital stay did not differ 
between the two cohorts: high-dose rocuronium median duration 2.2  (IQR 1.7-3.1) days 
vs. low-dose rocuronium 2.2 (1.3-3.3) days (p = 0.52). In both cohorts there were no im-
mediate postoperative respiratory complications or inadvertent admissions to intensive 
or intermediate care departments. 
readmission rates
In the two cohorts, 26 patients were readmitted within 30 days. In 7 patients, readmission 
was pre-planned (reasons for readmission: chemotherapy, learning how to catheterize, 
screening for kidney transplantation, reassessment of renal function, bisphosphonate 
treatment) occurring in both cohorts. In 19 (7.3%) patients readmissions was unplanned: 
5 (3.8%) in patients receiving high-dose rocuronium and 14 (10.8%) in patients receiving 
low-dose rocuronium (χ2 = 4.6, p = 0.03; odds ratio = 0.33, 95% C.I. 0.12-0.95). In Table 4 
the reasons for readmission are given. None of the patients died during readmission. See 
Table 4 for a specification of the data. In total 8 readmissions were related to an infection 
at the surgical site (1 in patients receiving high-dose rocuronium, 7 in patients receiving 
low-dose rocuronium).
Cost
Combined cost of relaxation and reversal was on average $131 (95% confidence interval 
$115-$147) per patient in the high-dose rocuronium cohort vs. $34 (95% confidence in-
terval $26-$42) in the low-dose cohort. All of these costs were paid by the hospital. Total 






Duration of surgery (hours; median, IQR) 2.4 (1.7-3.1) 2.3 (1.7-3.1) 0.77
Duration of anaesthesia (hours; median, IQR) 3.1 (2.4-4.1) 3.1 (2.4-4.1) 0.88
Stay in PACU (hours; median, IQR) 1.9 (1.4-2.2) 1.7 (1.2-2.2) 0.16
Mean arterial pressure (mmHg) 85 (10) 80 (11) < 0.01
Heart rate (beats.min-1) 68 (11) 69 (11) 0.48
Bi-spectral Index 42 (5) 44 (6) 0.03
Oxygen saturation (%) 99 (1) 99 (1)  0.95
Length of hospital stay (days; median, IQR) 2.2 (1.7-3.2) 2.2 (1.3-3.3) 0.52
PACU = post-anaesthesia care unit; IQR = interquartile range. Values are mean (SD) unless otherwise stated
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reimbursement from reimbursement agencies for readmissions (at the benefit of the 
hospital) was $116,000 for the 14 patients in the low-dose rocuronium cohort against 
$42,000 for the 5 patients in the high-dose rocuronium cohort (average reimbursement 
per patient was similar between the 2 cohorts at approx. $8,300 per patient).
DisCussion
This retrospective matched cohort study presents data of the everyday clinical use of 
high-dose rocuronium neuromuscular block for elective laparoscopic retroperitoneal 
surgery in a single tertiary academic hospital in the Netherlands. A total of 130 patients 
who received high-dose rocuronium anaesthesia (and reversal with sugammadex) were 
compared to 130 matched patients that received low-dose rocuronium anaesthesia (to 
induce a moderate NMB). The main finding of this study is that the administration of 
high-dose rocuronium is associated with reduced unplanned readmission rates in the 
30 days following elective surgery (3.8% vs. 12.7%). Furthermore, the application of 
high-dose rocuronium anaesthesia was without inadvertent admissions to intensive or 
intermediate care departments. 













Male/female (n/n) 4/1 13/1





CKD stage 1-3 5 13
CKD stage 4 and 5 0 1
Reasons for readmission -  Abscess in renal bed 
- Brain metastasis
- Enteritis
- Lymphocele (n = 2)
- Collapse/hypotension
- Enteritis and transient ischemic attack
- Intra-abdominal urinary leak
- Complicated urinary tract infection (n = 7) 
- Urinary retention
- Lymphocele
- Urethra/bladder anastomosis leak
- Worsening of renal function (CKD stage 2 to 3)
CKD chronic kidney disease. CKD = stage 1-3: glomerular filtration rate ≥ 30 mL/min; CKD stage 4 and 5: 
glomerular filtration rate < 30 mL/min.
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Neuromuscular blocking agents are routinely used in anaesthesia to facilitate endo-
tracheal intubation and improve surgical conditions.1, 2 A recent meta-analysis of 12 
randomized controlled trials concluded that high-dose rocuronium NMB (intended to 
achieve deep NMB with PTC 1-3 twitches)  improves surgical conditions in a variety of 
procedures as determined by the scoring of the surgical space conditions by the at-
tending surgeon.22 In most studies included in this review, the applied scoring systems 
combine the impression of visibility, surgical space, muscle contractions, handling 
tactics and patient movement into one numerical rating score. In all studies, the effect of 
the high-dose rocuronium NMB on the score is modest (on average the score improves 
by about 20%) but considered highly clinically significant by the surgical team.3, 4 Still, 
the risk of postoperative complications from residual NMB has historically precluded 
the use of high doses of muscle relaxants for many years.11, 12 With the introduction of 
sugammadex, quick and safe reversal of high-dose rocuronium NMB became possible.14 
In our institute we now provide high-dose rocuronium anaesthesia upon request of 
the surgeons to allow a stable and qualitatively superior surgical space conditions in a 
variety of procedures.
Our current analysis shows that the both cohorts did not differ in hemodynamics, 
duration of surgery and anaesthesia or immediate postoperative conditions, including 
postoperative pain. A small difference in depth of anaesthesia and mean arterial pres-
sure was observed although we do not consider these differences clinically relevant. 
We previously identified a small positive effect of high-dose rocuronium NMB on 
postoperative pain scores following bariatric surgery but not following retroperitoneal 
urologic procedures.3, 4 The above mentioned meta-analysis of 12 studies also revealed a 
small advantage of high-dose rocuronium NMB over standard or low-dose rocuronium 
NMB with an improvement in postoperative numerical pain scores of 0.5 on an 11-point 
scale.22 These data suggest that the effect of high-dose rocuronium NMB on pain scores 
is small. Different procedures may activate specific pathophysiologic pain pathways 
that interact differently with the high-dose rocuronium NMB. In the current analysis we 
focus on retroperitoneal surgeries. These procedures are associated with relatively low 
pain scores and little effect of high-dose rocuronium NMB.3 Hence, our analysis does not 
allow definite conclusions regarding the influence of high-dose rocuronium NMB on 
postoperative pain.  
We encountered a reduction in unplanned readmission rates from 12.7% in the low-
dose to 3.8% in the high-dose rocuronium cohort (Table 4). Readmissions after surgery 
are relatively common, with rates ranging from 4-16% after major urologic surgery and 
9-20% after colorectal surgery.23, 24 Readmission after surgery represents a major cost for 
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the health care system. For instance, readmission after colorectal surgery costs $9000 
per readmission; this annually accounts for $300 million in the US alone.25 To address 
and reduce costs, readmission is increasingly being used as a hospital quality indicator 
by reimbursement agencies. In the US, as a part of the Hospital Readmission Reduc-
tion Program, reimbursements may be denied in case of excessive readmission rates.26 
The cost of readmission to reimbursement agencies in our institute is approximately 
$8,300 per patient. Given the reduction in readmissions observed in patients receiving 
high-dose rocuronium anaesthesia (combined with sugammadex reversal) compared 
to patients receiving low-dose rocuronium anaesthesia, there is a potential financial 
benefit to the healthcare system that could offset the costs associated with high doses 
of rocuronium and sugammadex made by the hospital. As this retrospective data may 
be biased due to changes in surgical and/or anaesthesia practice over time, possible 
inaccuracies in the dataset or its retrieval from HIX or PDMS or other relevant limitations 
(see below), a prospective randomized pharma-coeconomic trial should be considered 
to definitely capture relevant cost data.
Known risk factors for readmission include older age, comorbid conditions, length of 
procedure, surgery complexity and intra- and postoperative complications.16-20, 27 Due to 
matching, in our study all relevant factors were comparable at baseline (Tables 1 and 2). 
We therefore account the application of high-dose rocuronium anaesthesia as the most 
important factor associated with the lower readmission rates. Although our study does 
not answer the question why better chemical relaxation results in improved surgical 
outcome, we believe that it is important to discuss possible mechanisms. All procedures 
were performed in the retroperitoneal space, where working space is very limited. As 
previously shown, high-dose rocuronium NMB leads to superior scoring of the surgical 
space conditions in these retroperitoneal surgeries.3, 22 Possibly, the improved surgical 
conditions in the narrow space of retroperitoneal laparoscopic surgery during high-dose 
rocuronium NMB contribute to superior technical performance of the surgeon and less 
trauma to tissue. A recent review supports this hypothesis by concluding that superior 
technical performance positively affects patient outcome.28 An important reason for 
readmission was an infectious complication of the urinary tract (complicated urinary 
tract infection including pyelonephritis and urosepsis). We hypothesize that urinary 
tract tissue is particularly susceptible to infection when surgical space conditions are 
less optimal and/or urinary tract tissue is more frequently or more intensely manipu-
lated (causing micro trauma). Additionally, it is important to realize that NMB agents 
possess anti-inflammatory properties through actions at the nicotinic acetylcholine 
receptor α1.29 The high-dose rocuronium infusion may therefore have had some tissue 
protective effect leading to less postoperative complications. Reduced glomerular filtra-
tion rate (chronic kidney disease, CKD, stage 4 and 5 with a glomerular filtration rate 
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< 30 mL.min-1) affects rocuronium clearance. This may be a cause of residual NMB and 
postoperative complications, especially in those patients that are not or inadequately 
monitored. However in patients with complications that required readmission just 1 
patient receiving low-dose rocuronium and none receiving high-dose rocuronium had 
CKD stage 5 (Table 4). The reason for readmission in this one particular patient was se-
vere enteritis and a transient ischemic attack. Consequently, we do not think that renal 
function influenced the outcome of our study. Finally, in other surgery types such as 
ophthalmology, we did not observe a difference in readmission rates (data not shown). 
This suggests that the improved outcome in our study is most importantly related to the 
type and site of surgery. 
Our study has various limitations that need to be considered: 
(1) Since the use of high-dose rocuronium anaesthesia is relatively new to our clinical 
practice, we were able to just include a small number of patients in our analysis. 
This small sample precluded the analysis of underlying contributing risk factors as a 
cause of readmission. 
(2) We remain unaware whether the results of our study are related to the high-dose 
rocuronium infusion, the reversal with sugammadex or to both. The number of pa-
tients that received sugammadex in the low-dose rocuronium cohort was too small 
to perform a separate analysis. 
(3) This is a single-center study and generalizability to other centers is likely to be lim-
ited. For example, the use of a rocuronium infusion (and reversal with sugammadex) 
is not standard care in other hospitals in Europe or the US. 
(4) This is a non-randomized study with a non-contemporaneous control group. We 
cannot exclude that temporal changes in anaesthesia or surgical care may have 
contributed to the study outcome. 
(5) More subjects in the high-dose rocuronium group received the opioid remifentanil 
and irrespective of the type of opioid, the opioid dose was higher in the high-dose 
rocuronium group. This is a surprising observation that so far remains unexplained. 
We do not perceive a role for the difference in opioid dose in our study outcome, 
although it might explain the slightly deeper levels of anaesthesia in the high-dose 
rocuronium cohort (Table 3). 
(6) Our dataset lacks complete TOF data, as TOF measurements are not automatically 
recorded in our electronic patient database system. Although neuromuscular moni-
toring devices are available in all our operating rooms and monitoring is manda-
tory by local protocols, it cannot be ruled out that part of the patients were in fact 
inadequately or not monitored, especially in the low-dose rocuronium group. This 
may be a source of residual confounding, however to what extent this influenced our 
study remains unclear. 
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Evidently, further prospective randomized controlled trials (with appropriate monitor-
ing) in larger populations are required to determine causal inferences between the 
relaxant dose and patient outcome and a possible role for the reversal agent on patient 
outcome.
In conclusion, this small retrospective study presents the first real world data of the 
effect of a high-dose rocuronium/sugammadex anaesthetic technique on postopera-
tive outcome. Our data indicate that the use of a high-dose rocuronium/sugammadex 
technique is associated with reduced readmission rates in the 30 days following elec-
tive laparoscopic retroperitoneal surgery compared to low-dose rocuronium infusions. 
Given the study limitations, future prospective randomized studies in larger samples are 
needed to further investigate the benefit of high-dose relaxants on patient outcome. 
Additionally, the prospective study of the pharmaco-economic effect of such practice 
taking into account benefit (reduced readmission rates) and harm (cost of relaxants and 
reversal agents) is needed. 
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oxygenation following reversal of 
moderate neuromuscular block 
with sugammadex compared to 
neostigmine 
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Incomplete recovery of neuromuscular block (NMB) at the end of surgery is one of 
the leading causes of postoperative adverse events, most importantly hypoxaemia. 
Adequate reversal of NMB may overcome these complications. This study was designed 
to compare reversal with neostigmine and sugammadex on postoperative oxygenation 
during the first 45 minutes postoperatively.
methods 
In this randomized controlled, double-blind trial, 100 patients received propofol/sufen-
tanil/rocuronium anaesthesia and were randomized to NMB reversal at 1-2 twitches in 
the train of four (TOF) with sugammadex 2 mg.kg-1 or neostigmine 2.5 mg. Extubation 
was based on clinical signs of adequate muscle strength. Postoperative use of supple-
mental oxygen was not allowed unless saturation dropped to values below 94%.
results 
Mean (SD) TOF ratio at extubation was 0.74 (0.22) in patients reversed with neostigmine; 
70% of these patients had a TOF ratio < 0.9. In contrast, patients reversed with sugam-
madex had a TOF ratio of 0.99 (0.3) (p < 0.0001 vs. neostigmine); 4% of these patients 
had a TOF ratio < 0.9. Postoperatively, the lowest oxygen saturation was 96.8 (2.2)% 
against 93.3 (3.9)% in sugammadex and neostigmine groups, respectively (p < 0.0001). 
The combination of TOF ratio > 0.90 and oxygen saturation levels ≥ 94% occurred in 
90% of patient reversed with sugammadex compared to 16% of patients reversed with 
neostigmine.
Conclusions 
Compared to reversal with neostigmine, reversal of a moderate neuromuscular block 
with sugammadex resulted in improved muscle function at extubation with less postop-
erative hypoxaemia in patients not receiving supplemental oxygen.
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inTroDuCTion
Neuromuscular blocking agents are routinely used during general anaesthesia to opti-
mize intubation and improve surgical conditions. For example, we recently showed that 
a deep neuromuscular block (NMB) improves the quality of the surgical field in retroperi-
toneal laparoscopic surgery.1 The persistence of some level of NMB (residual relaxation 
defined by a train-of-four (TOF) ratio < 0.9) is an independent risk factor for postopera-
tive pulmonary complications, with hypoxaemia as most frequent event.2, 3 We relate the 
relatively high incidence of residual relaxation following general anaesthesia to the lack 
of adequate quantitative monitoring (but instead subjective monitoring based on clini-
cal signs of recovery) and the impatience of the anaesthetist (not realizing that reversal 
with some agents is relatively slow). For example, even when the NMB is reversed with 
the acetylcholinesterase inhibitor neostigmine residual relaxation is a frequent observa-
tion in the PACU, independent of the use of monitoring.4 We previously showed that 
more than 30% of patients experience frequent hypoxic events in their 45 min stay in 
the PACU following isoflurane/fentanyl-based anaesthesia with spontaneous recovery 
or reversal with neostigmine of a moderate NMB.5 The link between residual relaxation 
and hypoxaemia in the PACU is that persistence of even low levels of acetylcholine re-
ceptor blockade cause inadequate pulmonary and upper airway muscle function as well 
as reduced carotid body activity.6-8 Consequently, alveolar hypoventilation combined 
with loss of upper airway patency and a reduced ventilatory response to hypoxaemia 
facilitates frequent hypoxic events in the PACU. 
A relatively new reversal agent is the γ-cyclodextrin sugammadex, which encapsulates 
rocuronium (and vecuronium) in plasma and consequently causes the diffusion of the 
NMB agent from the neuromuscular junction.9 While several studies show that sugam-
madex causes rapid and complete reversal of moderate and deep NMB,10-13 a recent 
study showed that even following sugammadex reversal residual relaxation (defined 
by a train-of-four (TOF) ratio < 0.9) occurred in 4% of patients.14 No data are available 
on the incidence of hypoxaemia in the PACU following reversal with sugammadex or 
the association between TOF ratio at extubation following sugammadex reversal and 
oxygen saturation levels in the PACU. 
We conducted a double-blind randomized controlled trial comparing the effect 
of reversal of a moderate NMB (TOF 1-2 twitches) with sugammadex 2 mg.kg-1 and 
neostigmine 2.5 mg on oxygen saturation levels in the PACU. The use of supplemental 
oxygen in the PACU was not allowed unless arterial oxygen saturation dropped to values 
below 94%. We hypothesize that, compared to neostigmine, reversal with sugammadex 




The study with acronym Neuropa was conducted between February 2015 and February 
2016 at two medical centres in the Netherlands, Leiden University Medical Centre in 
Leiden and Haga Ziekenhuis in The Hague. Ethics approval of the protocol was obtained 
from the ethics committees of both institutions; the protocol was registered at clinical-
trials.gov under number NCT02243943. The study was conducted in accordance with 
Good Clinical Practice and Good Research Practice guidelines. Eligible patients were 
approached in advance by one of the investigators and received oral and written infor-
mation about the study. If a patient was willing and able to participate, written informed 
consent was obtained. 
Patients and randomization
Patients were eligible to participate in the study if they fulfilled the following criteria: 18 
years or older, ASA class I-III, body mass index <35 kg.m-2, scheduled for elective surgery 
with a planned duration of at least 60 minutes and requiring general anaesthesia with 
the use of muscle relaxants. Exclusion criteria included known or suspected neuromus-
cular disorder, allergy to muscle relaxants or reversal agents, a (family) history of malig-
nant hyperthermia, (suspected) pregnancy or current breast feeding, contraindications 
for neostigmine use, planned regional or neuraxial anaesthesia, pulmonary disease and 
renal insufficiency (glomerular filtration rate < 30 mL.min-1).
All patients were randomized to receive either sugammadex or neostigmine as reversal 
agent at the end of surgery. Randomization was performed before induction of anaes-
thesia and the ‘time out” procedure. Randomization was performed using a computer-
generated randomization list (obtained from www.randomization.org). Allocation to 
treatment was at the end of surgery. The patient and researchers were fully blinded, but 
the attending anaesthetist was not and he or she administered the drugs at a train-of-
four (TOF) count of 1 (T1) or 2 (T2) twitches. Thereafter the anaesthetist was blinded to 
the TOF count and TOF ratio and his or her decision to extubate the patient was based 
on clinical grounds.  
anaesthesia and neuromuscular management
Premedication consisted of oral midazolam 3.75 to 7.5 mg and rectal paracetamol 1000 
mg one hour before surgery. All patients received total intravenous anaesthesia with 
sufentanil, propofol and rocuronium and inhaled a 50/50 mixture of oxygen and nitro-
gen. Monitoring was according to local practice and included electroencephalogram 
monitoring using the Philips BIS module (Philips, Eindhoven, the Netherlands). Target 
BIS values in this study were values between 45 and 55. Relaxation was measured using 
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the TOF cuff device (RGB Medical Devices, SA, Madrid, Spain), which was applied around 
the left or right upper arm, contralateral to the blood pressure cuff. The TOF cuff was cali-
brated after induction but before administration of rocuronium. The TOF cuff is equally 
reliable to acceleromyography and has been used in our previous studies on NMB.15 In 
our opinion, the TOF cuff is easier to use in daily practice than the TOF watch and is less 
prone to error. One hour before the end of surgery, morphine 0.1 mg.kg-1 was given. 
The target level of neuromuscular relaxation was T1 or T2 throughout the procedure 
until reversal. If measurement indicated a TOF of 3 twitches or higher during surgery, an 
incremental dose of rocuronium 10 mg was administered. At the end of the procedure, 
neuromuscular block was reversed with sugammadex 2 mg.kg-1 or neostigmine 2.5 mg 
(combined with atropine), according to randomization. Upon the discretion of the at-
tending anaesthetist additional doses could be given. At reversal, the inhaled oxygen 
concentration was set at 100%; lung recruitment manoeuvres were not allowed unless 
deemed necessary by the attending anaesthetist. 
Extubation was performed by the attending anaesthetist based on clinical signs as 
is commonly practiced in both medical centres. These signs include adequate level 
of spontaneous ventilation, eye opening, hand grip strength, 5s. head lift and tongue 
protrusion. A blinded research nurse collected TOF data at 1-minute intervals from the 
time of reversal. 
After extubation and transport to the PACU oxygen saturation (SpO2) was continuously 
monitored and recorded at 2-minutes intervals. Supplemental oxygen was only allowed 
when SpO2 dropped below 94%. The SpO2 was collected on the case record form and 
the lowest value observed in the PACU was used for analysis. Additionally, the following 
variables were recorded on the case record form at 15-minutes intervals: blood pressure, 
heart rate, pain (using an 11-point numerical rating scale from 0 to 10) and sedation 
(using a 5-point scale ranging from 0, normal alertness to 5, not aroused by a painful 
stimulus). After 45 minutes in the PACU the study ended.
sample size and statistics
We judged that a difference in SpO2 between treatment groups of at least 2% is clinically 
relevant. Assuming a SD of 3.0%, a sample size of 49 patients per group would provide 
at least 90% power to detect the observed difference at α = 0.05.
The primary outcome was the lowest SpO2 as measured during the first 45 minutes in 
the PACU. Data analysis was based on an intent-to-treat basis. A significant difference 
between treatment groups was tested by two-tailed Student t-test. Secondary outcomes 
were time to a TOF ratio > 0.9, time from reversal to extubation, postoperative pain level 
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and sedation scores in the PACU. Student t-tests and Mann Whitney U tests were used 
as appropriate. The data were analyzed with SPSS (version 22; IBM corporation, Armonk, 
NY, USA). All data are presented as mean (SD) or mean (95% confidence interval) unless 
otherwise stated. p-values < 0.05 were considered significant. 
resulTs
Figure 1 shows the flow diagram of the study. A total of 126 patients were contacted 
of whom 16  refused consent, 4 did not meet inclusion criteria and 6 patients could 
not enter the study due to logistic reasons (e.g. rescheduling of surgery). One-hundred 
patients were randomized between the treatment groups. No patients were lost to 
follow-up and postoperative data of all patients were used in the final analysis.
reversal
Table 1 gives the baseline characteristics and perioperative measurements. No signifi-
cant differences were present between both groups. In addition, no significant differ-
ences in duration of surgery and anaesthetic medication were present. At the end of 
surgery, relaxation was reversed at a mean TOF count of 1.4 (1.1-1.7) and 1.6 (1.2-1.9) 
twitches in sugammadex and neostigmine groups respectively (p > 0.05). Patients in 










Refusal of consent n= 16
Logistic reasons n= 6
Not meeting inclusion criteria n= 4
Analyzed
n=50
figure 1. Study flow chart.
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Age (years; median, range) 55 (27-72) 55 (19-94) NS
Male (n, %) 27 (53%) 24 (44%) NS
Weight (kg) 79 (75-83) 75 (71-79) NS
BMI (kg.m-2) 26 (25-27) 25 (24-26) NS
ASA (n, %) NS
  1 18 (35%) 32 (59%)
  2 32 (63%) 22 (41%)
  3 1 (2%) -
Preoperative saturation (%) 99 (98-99 99 (98-99) NS
surgerY
Duration of surgery (min) 107 (91-123) 90 (77-105) NS
Propofol dose (mg) 1114 (972-1256) 951 (803-1098) NS
Sufentanil dose (μg) 52 (45-58) 43 (38-49) NS
reversal
Sugammadex dose (mg) 170 (156-184) -
Neostigmine dose (mg) - 2.5 (2.4-2.6)
Atropine dose (mg) - 1.08 (1.03-1.13)
BIS at reversal 46 (44-49) 44 (42-46) NS
TOF count at reversal 1.4 (1.1-1.7) 1.6 (1.2-1.9) NS
Time to TOF ratio 0.9 (min) 2.5 (2.1-2.8) 10.0 (7.6-12.3) < 0.0001
exTubaTion
TOF ratio at extubation 0.99 (0.98-1.00)* 0.74 (0.68-0.80) < 0.0001
TOF ratio below 0.90 at extubation - 0.60 (0.55-0.67)**
Time to extubation from reversal (min) 8.0 (6.9-9.1) 11.7 (9.9-13.4) 0.01
Time to extubation from TOF 0.9 (min) 5.8 (4.7-6.8) 3.8 (2.1-5.4)# NS
BIS at extubation 79 (76-82) 77 (74-80) NS
PosT anaesThesia Care
Lowest Saturation in PACU (%) 96.8 (96.1-97.4) 93.3 (91.9-94.7) < 0.0001
Morphine dose (mg) 11 (10-12) 11 (9-12) NS
Pain score (NRS) 3.0 (2.4-3.7) 3.2 (2.4-3.0) NS
Sedation score 1.4 (1.2-1.6) 1.4 (1.2-1.6) NS
Values are mean (95% confidence interval) unless otherwise stated; *n= 48; ** n = 35; # n = 20
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the neostigmine group received a mean of 2.5 (2.4-2.6) mg of the reversal agent. Eight 
patients (16%) required one additional neostigmine dose of 1 mg; three others (6%) 
received a dose of sugammadex after their initial neostigmine dose. Patients in the 
sugammadex group received 170 (156-184) mg; none received an additional dose of 
sugammadex or neostigmine. 
extubation
In 2 patients, TOF values could not be measured following sugammadex reversal due 
to patient movement and rapid extubation. Thirty-five patients (70%) treated with 
neostigmine had a TOF ratio < 0.9 upon extubation against 2 (4%) patients treated with 
sugammadex (Fig. 2). The TOF ratio at extubation was 0.74 (0.71-0.83; n = 50) in the 
neostigmine group and 0.99 (0.98-1.00; n = 48) in sugammadex group (p < 0.0001). In 
the 35 patients reversed with neostigmine that had a TOF ratio < 0.9 their average ratio 
was 0.60 (0.55-0.67); the two patients reversed with sugammadex that had a ratio < 0.9 
had ratios of 0.88 and 0.82. In those subjects that reached a TOF ratio of 0.9 or greater, 
the time from reversal to a TOF ratio > 0.9 was significantly shorter in the sugammadex 
group, 2.5 (2.1-2.8; n = 48) minutes, compared to the neostigmine group, 10.0 (7.6-12.3; 
n = 15) minutes (p < 0.001). The time from reversal to extubation was shorter for sugam-
madex, 8.0 (6.9-9.1; n = 50) minutes, compared to neostigmine, 11.7 (9.9-13.4; n = 50) 


























TOF ratio <0.9 at extubation
4% sugammadex
70% neostigmine
figure 2. Train-of-four ratio at extubation following reversal with sugammadex or neostigmine .
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Post-anaesthesia care
The main outcome, lowest SpO2 in the 45 minutes following reversal, was 3.5% lower 
in patients treated with neostigmine compared to patients treated with sugammadex: 
93.3 (91.9-94.7)% against 96.8 (96.1-97.4)% (p < 0.0001). Figures 3A and 3B show the 
distribution of the lowest SpO2 per group and highlight the difference in SpO2 distribu-
tion for the two treatments. Figure 4 shows the individual lowest saturation values in 
the PACU in relation to TOF ratio at extubation. In the sugammadex group, 90% of the 
patients were in the upper right quadrant of the graph (TOF ratio of > 0.9 combined with 
lowest saturation ≥ 94%), while for neostigmine treated patients just 16% of patients 
were in the upper-right quadrant.






























figure 3. Frequency distribution of the lowest oxygen saturation values measured in the PACU following 
reversal with sugammadex (a) and neostigmine (b).


























































figure 4. Lowest saturation values measured in the PACU versus train-of-four ratio’s at extubation for su-
gammadex (a) and neostigmine (b).
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In the PACU, no significant differences in sedation and pain scores were observed. No 
adverse events occurred.
DisCussion
This double-blind, randomized, controlled trial compared the effect of reversal of a 
moderate neuromuscular block (NMB) with sugammadex and neostigmine on oxygen 
saturation levels in postoperative patients. The main results are that NMB reversal with 
sugammadex resulted in less patients with postoperative hypoxaemia (defined by SpO2 
levels < 94%) compared to neostigmine in patients not receiving supplemental oxygen. 
Low SpO2 levels are not uncommon in the PACU and are related to multiple factors, 
including residual effects of opioids and anaesthetics, type of surgery, patient charac-
teristics, underlying disease, the use of recruitment manoeuvres and the inhaled oxygen 
concentration during anaesthesia and recovery. Since these factors were either evenly 
distributed between the two treatment groups or tightly controlled according to pro-
tocol, we hold the intervention (sugammadex versus neostigmine) responsible for the 
large difference in SpO2 distribution in the PACU (Figs. 3 and 4). Reversal of the NMB 
with neostigmine resulted in SpO2 levels < 94% in 47% of patients compared to 8% of 
patients after reversal with sugammadex. On average SpO2 levels (i.e. lowest measured 
SpO2) were 3.5% lower after neostigmine (neostigmine 93.3% vs. sugammadex 96.8%). 
Our data support the growing body of evidence showing that neostigmine reversal is 
associated with an increased risk of postoperative respiratory complications such as hy-
poxaemia,10, 16-18 and additionally show the beneficial effect of sugammadex with signifi-
cantly less risk of postoperative hypoxaemia. These are important results and indicate 
that the choice of reversal agent has a significant effect on postoperative conditions. 
This is the first study that measured residual NMB at extubation in conjunction with 
postoperative SpO2 levels in patients that did not receive supplemental oxygen. By 
initially restricting the use of oxygen in the PACU, the masking effect of supplemental 
oxygen on the measured SpO2 levels was absent and hypoxaemia related to hypoven-
tilation either from reduced respiratory drive or from persistent muscle weakness (or 
hypoxaemia from any other cause) was now readily detected.19, 20 Consequently, we 
were able to identify a significant difference in postoperative oxygenation between 
treatments in a relatively healthy population. The difference between treatments was 
however relatively small (3.5%) since we administered supplemental oxygen by mask or 
nasal cannula when SpO2 dropped below 94%. Evidently, this was done to prevent any 
harm to the patient. It is highly probable, however, that in a more susceptible population 
the difference in SpO2 would have been more pronounced. Such populations include 
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patients with pulmonary disease, muscle weakness, heart failure, elderly patients and 
ASA class 3-4 patients. 
Neostigmine is commonly used upon spontaneous recovery of muscle relaxation (i.e. 
T > 0). In the current study we administered neostigmine 2.5 mg at T1 or T2. The use of 
neostigmine at T1 or T2 is not unusual, although in most studies the dose is higher than 
used by us.21, 22 In the two institutions in which the study was performed, neostigmine 
is generally used at T > 0 in doses of 1 to 2.5 mg, irrespective of the patient’s weight 
and without proper NMB monitoring. Our current data indicate that this practice is as-
sociated with slow recovery, residual curarization at extubation (in 70% of patients) and 
hypoxic events in the PACU (in 47% of patients). In Figure 4, we associate the TOF ratio 
at extubation with the lowest SpO2 in the PACU and observed that 90% of patients had 
a TOF ratio of > 0.9 combined with saturation levels of 94% or above following sugam-
madex (upper-right quadrant of Fig. 4), compared to 16% after neostigmine reversal. 
Possibly higher neostigmine doses might have improved either of these outcomes,22 
however, it is our experience that higher neostigmine doses come at the expense of 
uncomfortable cholinergic side effects such as nausea, vomiting, abdominal cramps and 
blurred vision. Given the results of our current study we changed our practice and now 
routinely reverse a moderate NMB with sugammadex 2 mg.kg-1. 
We observed a TOF ratio < 0.9 at extubation in 70% of patients after neostigmine and 
4% after sugammadex reversal. The incidence of residual block varies widely among 
studies, with incidences ranging from 2% to 64%, depending on definition, clinical 
circumstances, agents used and timing of measurements.4 For example, Murphy et al.23 
and Fortier et al.24 observed residual curarization in 63% to 88% of patients at extuba-
tion following predominantly neostigmine reversal; in agreement with our study, the 
anaesthetists were blinded to NMB monitoring. Brueckmann et al.10 performed mea-
surements in the PACU and detected TOF ratio values < 0.9 in 43% and 0% following 
neostigmine and sugammadex treatment, respectively.10 We contend that similar values 
may have occurred in our patients in the PACU. We did not measure TOF ratio’s in the 
PACU to prevent possible respiratory stimulation from TOF measurements. An important 
observation was made by Kotake et al. who studied sugammadex reversal and detected 
an incidence of residual NMB of 4% in a setting where no monitoring was used.14 These 
findings are in agreement with our results and emphasize the importance of neuromus-
cular monitoring.
In our current study extubation was performed under “blinded” conditions (i.e. the 
anaesthetist was unaware of the number of twitches and TOF ratio). This practice is very 
similar to standard of practice in many institutions. The use of monitoring at extubation 
might have reduced the incidence of residual curarization in both groups and possibly 
might have improved oxygenation in the PACU. The effect of reversal with neostigmine 
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versus sugammadex on SpO2 levels in the PACU in a monitored setting should be as-
sessed in future studies. 
In conclusion, we show that the selection of reversal agent controls not only the speed 
and intensity of recovery of the neuromuscular block, but additionally has a significant 
effect on postoperative respiratory conditions. Both the TOF ratio at extubation and 
the oxygen saturation levels in the PACU differ significantly in patients reversed with 
neostigmine and sugammadex with favorable conditions for both end-points in 90% of 
patients after sugammadex versus just 16% of patients after neostigmine reversal.  
Sugammadex vs. neostigmine and postoperative oxygenation 81
5
referenCes
 1  Martini CH, Boon M, Bevers RF, Aarts LP, Dahan A. Evaluation of surgical conditions during laparo-
scopic surgery in patients with moderate vs deep neuromuscular block. Br J Anaesth 2014; 112: 
498-505
 2  Berg H, Roed J, Viby-Mogensen J, et al. Residual neuromuscular block is a risk factor for postopera-
tive pulmonary complications. A prospective, randomised, and blinded study of postoperative 
pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesio-
logica Scandinavica 1997; 41: 1095-103
 3  Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS. Residual neuromuscu-
lar blockade and critical respiratory events in the postanesthesia care unit. Anesth Analg 2008; 
107: 130-7
 4  Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned. Part I: definitions, inci-
dence, and adverse physiologic effects of residual neuromuscular block. Anesth Analg 2010; 111: 
120-8
 5  Dahan A. General anesthesia and the control of respiration. Seminars Anesth 1996: 328-34
 6  Eikermann M, Groeben H, Husing J, Peters J. Predictive value of mechanomyography and ac-
celerometry for pulmonary function in partially paralyzed volunteers. Acta Anaesthesiologica 
Scandinavica 2004; 48: 365-70
 7  Eriksson LI, Lennmarken C, Wyon N, Johnson A. Attenuated ventilatory response to hypoxaemia 
at vecuronium-induced partial neuromuscular block. Acta Anaesthesiologica Scandinavica 1992; 
36: 710-5
 8  Eriksson LI, Sundman E, Olsson R, et al. Functional assessment of the pharynx at rest and during 
swallowing in partially paralyzed humans: simultaneous videomanometry and mechanomyogra-
phy of awake human volunteers. Anesthesiology 1997; 87: 1035-43
 9  Welliver M, McDonough J, Kalynych N, Redfern R. Discovery, development, and clinical applica-
tion of sugammadex sodium, a selective relaxant binding agent. Drug Des Devel Ther 2009; 2: 
49-59
 10  Brueckmann B, Sasaki N, Grobara P, et al. Effects of sugammadex on incidence of postoperative 
residual neuromuscular blockade: a randomized, controlled study. Br J Anaesth 2015; 115: 743-51
 11  de Boer HD, Driessen JJ, Marcus MA, Kerkkamp H, Heeringa M, Klimek M. Reversal of rocuronium-
induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding 
and safety study. Anesthesiology 2007; 107: 239-44
 12  Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gomez JA. Su-
gammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared 
with neostigmine: a multicenter, randomized, controlled trial. Anesth Analg 2010; 110: 64-73
 13  Sacan O, White PF, Tufanogullari B, Klein K. Sugammadex reversal of rocuronium-induced neuro-
muscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine. 
Anesth Analg 2007; 104: 569-74
 14  Kotake Y, Ochiai R, Suzuki T, et al. Reversal with sugammadex in the absence of monitoring did 
not preclude residual neuromuscular block. Anesth Analg 2013; 117: 345-51
 15  Rodiera J, Serradell A, Alvarez-Gomez JA, Aliaga L. The cuff method: a pilot study of a new method 
of monitoring neuromuscular function. Acta Anaesthesiologica Scandinavica 2005; 49: 1552-8
 16  Bissinger U, Schimek F, Lenz G. Postoperative residual paralysis and respiratory status: a com-
parative study of pancuronium and vecuronium. Physiological research / Academia Scientiarum 
Bohemoslovaca 2000; 49: 455-62
82 Chapter 5
 17  Grosse-Sundrup M, Henneman JP, Sandberg WS, et al. Intermediate acting non-depolarizing 
neuromuscular blocking agents and risk of postoperative respiratory complications: prospective 
propensity score matched cohort study. BMJ (Clinical research ed) 2012; 345: e6329
 18  Sasaki N, Meyer MJ, Malviya SA, et al. Effects of neostigmine reversal of nondepolarizing neuro-
muscular blocking agents on postoperative respiratory outcomes: a prospective study. Anesthe-
siology 2014; 121: 959-68
 19  Niesters M, Mahajan RP, Aarts L, Dahan A. High-inspired oxygen concentration further impairs 
opioid-induced respiratory depression. Br J Anaesth 2013; 110: 837-41
 20  Dahan A, Douma M, Olofsen E, Niesters M. High inspired oxygen concentration increases the 
speed of onset of remifentanil-induced respiratory depression. Br J Anaesth 2016; 116: 879-80
 21  Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Pedersen HS, Jensen EW. 
Optimum time for neostigmine reversal of atracurium-induced neuromuscular blockade. Can J 
Anaesth 1996; 43: 932-8
 22  Srivastava A, Hunter JM. Reversal of neuromuscular block. Br J Anaesth 2009; 103: 115-29
 23  Murphy GS, Szokol JW, Marymont JH, Franklin M, Avram MJ, Vender JS. Residual paralysis at the 
time of tracheal extubation. Anesth Analg 2005; 100: 1840-5
 24  Fortier LP, McKeen D, Turner K, et al. The RECITE Study: A Canadian Prospective, Multicenter Study 








The use of surgical rating scales for 
the evaluation of surgical working 
conditions during laparoscopic 
surgery. A scoping review 
Martijn Boon, Christian Martini, Leon Aarts, Albert Dahan




Surgical ratings scales (SRS) enable the surgeon to uniformly quantify surgical working 
conditions. They are increasingly used as a primary outcome in studies evaluating the 
effect of anaesthesia or surgery related interventions on the quality of the surgical work 
field. SRS are especially used in laparoscopic surgery due to a renewed interest in deep 
neuromuscular block. There are however no guidelines regarding the uniform use of SRS 
and the uniform reporting of results. 
methods 
A systematic search was conducted in the databases of PubMed, Web of Science and 
Embase for studies that reported the use of an SRS to evaluate surgical conditions in 
laparoscopic surgery. Only original human research in English language with full text 
availability through the Leiden university library were considered for this review. The full 
texts of eligible abstracts were independently reviewed by the first and second author. 
The quality of SRSs and methodology of rating were systematically reviewed.
results 
The search yielded 2830 reports, of which 17 were identified using a surgical rating scale 
in laparoscopic surgery. Ten of these reports used a unique SRS, these were systemati-
cally appraised for their quality. The overall quality of the SRSs was low: the majority of 
the scales were poorly described and lacked assessment of inter- and intra rater reli-
ability. In addition, considerable differences exists in the methodology of rating and the 
reporting of results. 
Conclusion 
There is substantial inconsistency in SRS quality, methodology and results reporting. 
The uniform use of high quality surgical rating scales is needed to improve the quality 
and reproducibility of future research. 
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inTroDuCTion
Surgical rating scales (SRS) are increasingly used to rate the quality of surgical working 
conditions. A SRS enables the surgeon to translate his or her experienced but subjective 
impression of the quality of the operative conditions into a standardised rating. The use 
of SRSs has potential benefits in daily practice and research. First, it offers a uniform 
platform for the surgeon to negotiate with the anaesthetist whether or not to improve 
or consolidate surgical working conditions induced by the anaesthetic. Second, surgical 
rating scales may be used in research to evaluate interventions and new techniques 
aimed at improving the surgical working / operating conditions. Recent developments 
in the reversal of neuromuscular block by sugammadex has renewed the interest in the 
effect of deeper levels of neuromuscular block (NMB) on surgical working conditions in 
laparoscopic surgery. In these studies, surgical rating scales are often used as primary 
outcome.1-8 However, guidelines on the use of surgical rating scales do not exist as yet. 
This systematic review gives an overview of the use of SRSs in laparoscopic surgery and 
proposes guidance for future research.
meThoDs
The first author conducted a literature search assisted by the librarian of the Leiden 
University Medical Centre. The following query was used to search the pubmed da-
tabase: (“rating scale”[tw] OR “rating scales”[tw] OR  “Visual Analog Scale”[Mesh]  OR 
Visual Analogue Scale*[tw] OR Visual Analog Scale*[tw] OR “scale”[tw] OR “scales”[tw] 
OR scaling*[tw] OR rating*[tw] OR scoring*[tw] OR “score”[tw] OR “scores”[tw] OR 
“scored”[tw] OR “grading”[tw] OR “grade”[tw] OR “graded”[tw]) AND (“surgical 
conditions”[tw] OR “surgical condition”[tw] OR “operating conditions”[tw] OR “operating 
condition”[tw] OR “surgical quality”[tw] OR “surgery quality”[tw] OR “surgical field”[tw]). 
Embase and Web of Science were searched with a similar query containing the following 
terms: “rating scale” “visual analogue scale”(included Mesh term), “scale”, “rating”, “scor-
ing”, “score”, “grading”, ”surgical conditions”, “operating conditions”, “surgical quality”, 
“surgical field”. The databases were searched on the 20th may 2017, without date range 
limit. The results were screened on title and abstract by the first author. Relevant full text 
articles were retrieved and the reference lists of these articles were screened for any ad-
ditional missed papers (snow ball method). After this first selection, the full texts of the 
selected articles were reviewed by the first and second author for inclusion in the review.
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study inclusion criteria
Studies included in this systematic review were limited to original randomized con-
trolled trials, English language and full text availability through the Leiden University 
full text access service. Articles were included if the study: (1) described a method to 
evaluate a surgical working condition or operating field or (2) applied a surgical rating 
scale or evaluation of surgical conditions in (3) laparoscopic surgery. Included publica-
tions were assessed for the following items: type of rating scale, description of the scale 
items, number of raters, scoring moments, validation methods, and reporting of results. 
exclusion criteria
Reports that did not score surgical conditions as a whole, but only specific subparts such 
as “satisfaction of the surgeon”, were excluded. 
Quality assessment of the rating scales
In general, the quality of a measurement instrument is critically dependent on its con-
struct validity and reliability.9, 10 Construct validity refers to the quality of the data based 
on the scores from a measurement instrument and whether it adequately represents the 
underlying construct (i.e. the surgical working conditions).9  For construct validity the 
following domains are considered important: scale content, internal structure, response 
process, correlation to other variables and clinical consequences.9-11 These domains re-
flect both the internal quality of the rating instrument (scale content, internal structure, 
correlation to other variables) and how the rating instrument is used in practice (scoring 
methodology; response/rating process). To uniformly assess the quality of the identified 
SRSs in this review, an appraisal score was constructed. We are not aware of any pre-
existing scores for the appraisal of surgical rating scales. In the appraisal score, relevant 
previous mentioned domains were translated into the following psychometric items: (1) 
scale length, (2) description of the scale items, (3) test-retest reliability and (4) correlation 
with other variables (see table 1). The appraisal score only assesses internal SRS quality; 
the scoring methodology is discussed separately. All SRSs were independently reviewed 
by the first and second author with the use of the appraisal score. Discrepancies were 
resolved by consensus. We will briefly explain the separate items of the appraisal score.
Length of the SRS. An SRS length of 5-7 items is considered optimal. Test-retest reliability, 
internal consistency and discriminating power of scales with 5-7 items are generally 
superior to short scales (2-4 item points) or very large scales (>10 item points).12, 13 In 
our appraisal score, scales with a length of 5-7 items received one point. Scales that 
contained less than 5 or more than 7 items were not granted any points. 
Description of scale items. In a well-described scale, each item in the scale has a grade 
(i.e. moderate or excellent) plus a detailed description of the specific aspects of the 
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surgical working field for that grade. An example of an SRS with an adequate scale item 
description is the Leiden- surgical rating scale. This scale is presented in table 2.14 Scales 
that have an adequate description of the scale items were granted one point in the ap-
praisal score. Inadequate, or absence of detailed description of the scale items, resulted 
in 0 points in the appraisal score. 
Test-retest reliability. Test-retest reliability assesses the reproducibility of ratings by 
one rater (intra-observer reliability) or between two (or more) raters (inter-observer 
reliability). At best, an SRS was assessed for both. The appraisal score grants 1 point for 
Table 1. Appraisal score 
Length of the scale Points
< 5 items 0
5-7 items 1
>7 items 0





Inter rater reliability 1
Intra rater reliability 1
Both 2
Correlation with other variables  
No 0
Yes 1
Table 2. The Leiden- Surgical Rating Scale (L-SRS)
1 extremely poor conditions: The surgeon is unable to work due to coughing or due to the 
inability to obtain a visible laparoscopic field because of inadequate muscle relaxation. 
Additional muscle relaxants must be given.
2 Poor conditions: There is a visible laparoscopic field but the surgeon is severely hampered by 
inadequate muscle relaxation with continuous muscle contractions and/or movements with 
the hazard of tissue damage. Additional muscle relaxants must be given.
3 acceptable conditions: There is a wide visible laparoscopic field but muscle contractions 
and/or movements occur regularly causing some interference with the surgeon’s work. There 
is the need for additional muscle relaxants to prevent deterioration. 
4 good conditions: There is a wide laparoscopic working field with sporadic muscle 
contractions and/or movements. There is no immediate need for additional muscle relaxants 
unless there is the fear for deterioration. 
5 optimal conditions: There is a wide visible laparoscopic working field without any 
movement or contractions. There is no need for additional muscle relaxants.
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intra-observer and one point for and inter-observer reliability verification. Hence, the 
maximum score in the appraisal score for this domain was 2 points. 
Correlation with other variables. According to the domains of construct validity, a 
measurement instrument should be compared to another measurement instrument or 
variable that reflects the same underlying construct. In the appraisal score, if an SRS was 
compared with another scoring instrument or variable, it received one point. Absence of 
such a comparison would result in 0 points.
The appraisal scoring system is given in Table 1. The maximum score that an SRS could 




The initial search yielded 2,830 publications. After removing duplicates, non-English lan-
guage and non-human research, we screened 873 abstracts of which 763 non-relevant 
publications were discarded. The full texts of 110 reports were reviewed. The snowball 
method yielded 14 additional relevant studies. After full text review of 124 selected 
articles, 15 reports were excluded because (1) the SRS was not used for assessment 
of surgical conditions, or (2) surgical conditions were not scored. Another 92 reports 
were excluded because of non-laparoscopic surgery (3). In total, 17 publications were 
included in this review. Figure 1 outlines the selection process. The unique SRSs were 
systematically judged for their quality with the use of the appraisal score. Overall, the 
quality of the majority of the SRSs was low. (see table 3)










Martini14 2013 Urology 1 1 2 1 5
Caldwell25 1985 Gynaecology 0 1 0 0 1
Madsen17 2015 Gynaecology 1 0 0 1 2
Williams23 2003 Gynaecology 1 0 0 1 2
Dubois2 2014 Gynaecology 0 0 0 0 0
Blobner3 2014 General Surgery 0 0 0 1 1
Koo19 2016 General Surgery 1 0 0 1 2
Kim6 2016 General Surgery 1 0 0 0 1
Rosenberg22 2017 General Surgery 0 0 0 1 1
Taylor16 1992 General Surgery 1 0 0 1 2
0 = very poor quality; 5= excellent quality
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surgical rating scales used in laparoscopic surgery
Seventeen studies used a SRS for evaluation of surgical conditions in laparoscopic sur-
gery. 1-7, 15-24 The length of the individual scales varied between 3-, 4-, 5- ,6-, 11- and 100 
points. Most surgical rating scales were 4- or 5-point scales (see table 4). 
Four point scales are commonly used for evaluation of surgical conditions, pre-
dominantly laparoscopic gynaecologic surgery.2, 15, 17, 23 However, in the quality appraisal, 
these 4-point scales were rated as poor quality scales as the length of 4-point scales was 
considered suboptimal (<5 items) and all lacked test-retest reliability assessment.
Taylor et al. used a 5-point SRS to assess surgical conditions during cholecystectomy 
in relation to bowel distension and the use of nitrous oxide.16 This scale also lacked test-
retest reliability assessment. Martini et al. developed their 5-point Leiden - surgical rating 
scale (L-SRS) for use in laparoscopic retroperitoneal urologic surgery (see table 2).14 The 
scale was later successfully used in bariatric surgery.4 The scale items are well described 
and incorporate visibility of critical structures, working space, and muscle contractions 
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as determinants of the surgical working field.14 The 5-point L-SRS was assessed for inter-
rater reliability by the original research group.4, 14 In addition, Nervil et al. assessed both 
inter and intra-rater reliability of a modified version of the 5-point L-SRS and an 11-point 
SRS. 13 Both the 5-point and 11-point SRS showed excellent intra-rater reliability and 
fair inter-rater reliability. Due to the lower inter rater variability, the 5-point scale was 
considered superior. 13
The L-SRS scale is used by other research groups, including the use in laparoscopic 
donor nephrectomy. 5, 18, 20, 21. This endorses the utility of this scale. In laparoscopic donor 
nephrectomy, the L-SRS is used to titrate insufflation pressures to the lowest possible, 
whilst maintaining good operating conditions.  
methodology and results reporting
Most studies reported a mean SRS score and a distribution of the scores (see table 4). 
Some only reported the percentages of unacceptable surgical conditions, which was 
generally the frequency of scores on the lower half of the SRS.3, 15, 19 In addition, the 
number and moments of scoring differed considerably, with some studies scoring 
every 10- or 15-minutes,2, 4, 7, 14-16 while others scored one overall score at the end of 
surgery.3, 5, 8, 17-19, 22 Some reports do no mention a scoring interval at all.23, 24 In addition to 
the SRS, some have assessed other outcomes as well such as intra-abdominal space and 
the effect on insufflation pressures (see table 4).6, 15, 17, 19
Table 5. Guideline for future research
Surgical rating scale
I. Researches should only use pre-existing, validated scales available in their field of research, or (if 
unavailable)
II. Validate a pre-existing, high quality, non-validated scale in the field of interest (ie. assessment of inter- 
and intra-observer reliability), or
III. Develop and validate a new surgical rating scale with respect to the domains in the appraisal score
Use of the rating scale
I. Rating at multiple predefined moments during a procedure (instead of one rating at the end)
II. Report number and experience of scoring surgeons - raters
Reporting of results
I. Mean and/or median overall score
II. Mean/median score at every rating moment during a procedure
III. Distribution of the scores
IV. Clearly define (un)acceptable conditions (if applicable)
V. Compare SRS with other important variables.
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DisCussion
Surgical rating scales (SRS) are increasingly used in clinical research. These scales are 
used to translate the subjective perception of the surgical field by the surgeon into a 
more objective and reproducible integer on a fixed scale. Surgical rating scales are a 
useful tool to investigate the effect of surgery- or anaesthesia-related interventions on 
surgical working conditions. To get an indication on the variety of SRSs in use and their 
quality, we retrieved 17 relevant studies from the literature and identified 10 unique 
scales that are used in laparoscopic surgery. Since the introduction of sugammadex (a 
novel selective neuromuscular reversal agent), there has been a renewed interest in the 
application of deep neuromuscular block (NMB) in these types of surgery. This type of 
research relies heavily on the use of a SRS. 
Based on our results, it is evident that the large number of rating scales in literature 
comes with significant heterogeneity. There is ample difference in the quality of the 
rating scales and second, there is no uniformity in the method of rating and reporting 
of the results. In general, the quality of the rating scales was low. Most encountered 
problems were: absence of test- retest reliability assessment, absence of a comparison 
with a different scoring instrument and poor definition of the scale items. Only the 
Leiden - surgical rating scale received the highest quality score. (see table 3)
The methods of rating (rating methodology) and the reporting of the results of each 
study were also reviewed and revealed significant differences (see table 4). For example, 
the moment of rating (at fixed time points vs. at the end of surgery) and the number 
or raters (one vs. multiple) differed per study or was not detailed in the methods sec-
tion. This methodologic heterogeneity may impact results considerably. For instance, 
a surgical rating that is obtained at fixed time points during a procedure, i.e. every 15 
minutes, may give a different result compared to one “overall rating” rating at the end of 
a procedure.4, 5 Furthermore, the reporting of the SRS results varied considerably, with 
some reporting means or medians of the SRS, and others only the distribution of the 
SRS. 
In this review, we aimed to uniformly appraise the quality of the identified SRS. To 
be useful instruments, SRSs should display good psychometric properties, such as reli-
ability and validity, and also be easy to use.9-11 To this end, we created an appraisal score 
that was used to review these aspects of each SRS (see table 1). The appraisal score 
allowed us to uniformly assess the quality of each SRS. Note however, that the appraisal 
score is not evidence for validity of the results obtained with the SRS. Both validity and 
reliability are not inherent properties of the rating instrument, but they rather reflect the 
interaction of the scale with the measure being tested. We are aware that our appraisal 
score may possess shortcomings and lacks formal validation. Therefore, others may 
judge the quality of the SRS differently. Finally, it is important to realise that only English 
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language literature was searched and that useful, high quality rating scales may exist 
in non-English literature. In addition, high quality SRSs may exist in non-laparoscopic 
surgery, however this is beyond the scope of this review. 
The use of poor quality SRSs combined with poor rating methodology for research is 
undesirable, and reduces the validity of the results. While we do not intent to recom-
mend a preferred SRS for specific procedures, we do propose some guidance in the 
use of SRSs. If a good quality SRS in the field of interest is available, researchers should 
strongly consider using that scale. The use of existing SRSs increases the comparability of 
research. If validated SRSs are unavailable for specific surgical procedures, investigators 
can either choose to validate a pre-existing non-validated scale, or develop and validate 
a new scale. Any new developed scale should be of high quality. The items mentioned 
in the appraisal score can act as a guideline for this. The validation procedure should 
assess both inter- and intra-rater reliability of a scale. In addition, the scale should be 
compared with other variables to increase its validity. See table 5 for an overview of 
recommendations.
Finally, ratings should be obtained at predefined moments and researches should 
report the following in their methods and results: number of individuals involved in the 
scoring and their surgical experience, time-stamp of scoring, mean and/or median SRS 
values, mean/median scorings at each time-stamp, and the distribution of the scorings. 
Uniformity of these aspects, will improve comparability and reproducibility of this type 
of research.
In conclusion, this review found that multiple surgical rating scales have been used in 
laparoscopic surgery to assess the quality of the surgical field. The majority of the scales 
are of low quality and the method of rating and reporting of results differed consider-
ably. The uniform use of high quality surgical rating scales is needed to improve the 
quality and reproducibility of future research.
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Recent advances in neuromuscular 
blocking during anaesthesia




Muscle relaxation is a routine part of anaesthesia and has important advantages. 
However, the lingering effects of muscle relaxants in the postoperative period have 
historically been associated with postoperative adverse events. Neuromuscular reversal, 
together with neuromuscular monitoring, is a recognized strategy to reduce the rate of 
postoperative residual relaxation but has only marginally improved outcome in the past 
decades. 
Sugammadex, a novel reversal agent with unique encapsulating properties, has 
changed the landscape of neuromuscular reversal and opened new opportunities to 
improve patient care. By quickly and completely reversing any depth of neuromuscular 
block it may reduce the rate of residual relaxation and improve respiratory recovery. In 
addition, sugammadex has made the use of deep neuromuscular block possible dur-
ing surgery. Deep neuromuscular block may improve surgical working conditions and 
allow for a reduction in insufflation pressures during selected laparoscopic procedures. 
Whether and how this may impact outcomes is not well established. 
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inTroDuCTion
Muscle relaxants or neuromuscular blocking agents (NMBAs), introduced in 1942 by 
Griffith and Johnson, revolutionized the practice of anaesthesiology.1 NMBAs block neu-
romuscular transmission at the neuromuscular junction by binding to the postsynaptic 
nicotinic acetylcholine receptor. This renders these receptors unavailable for acetylcho-
line-mediated neuromuscular signal transmission (see Fig. 1). In practice, NMBAs enable 
anaesthetists to temporarily paralyze patients during anaesthesia. The introduction 
of NMBAs in anaesthesia meant that optimal surgical conditions (i.e. by ensuring an 
immobile patient) could be achieved with lower doses of volatile or intravenous anaes-
thetics, improving hemodynamic stability. Consequently, induction of muscle relaxation 
became an established part of the classic anaesthesia triad, alongside unconsciousness 
(hypnosis) and pain relief.2 However, like most medication, NMBAs are not devoid of 
disadvantages. Lingering effects of NMBAs in the postoperative period, also known as 
postoperative residual curarization (PORC), may cause life-threatening respiratory com-
plications in the first hours after surgery.3 In 1954, Beecher et al. were the first to note a 
six fold increase in anaesthesia-related mortality when NMBAs were used.4 Despite the 
development of short-acting agents and neuromuscular monitoring techniques, NMBAs 
continue to be associated with severe adverse events after anaesthesia, even today.5, 6 
figure 1. This figure shows the connection between the end of a motor neuron and a muscle fiber mem-
brane (also called neuromuscular junction). Signal transmission occurs by the release of acetylcholine (Ach, 
blue dots) from the neuron. Ach is able to open an ion-channel on the post synaptic muscle membrane, 
causing post synaptic membrane depolarization. Rocuronium is able to block signal transmission by inhib-
iting Ach to bind to the post synaptic ion-channel. The effect of rocuronium can be terminated by sugam-
madex, which encapsulates rocuronium in the blood plasma. 
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reversal of neuromuscular block
Currently two concepts of neuromuscular reversal exist. A moderate neuromuscular 
block (moderate NMB; see below) is traditionally reversed with an acetylcholinesterase 
inhibitor such as neostigmine. These drugs increase the amount of acetylcholine in the 
neuromuscular junction by inhibiting the enzyme acetylcholinesterase. The increased 
levels of acetylcholine compete with the NMBA molecules for the postsynaptic nicotine 
receptors (i.e. competitive antagonism) and tip the balance towards enhanced signal 
transmission. Encapsulation of NMBA molecules by sugammadex represents a novel 
reversal strategy. Sugammadex is a modified y-cyclodextrin, which is able to selectively 
bind free plasma NMBA molecules (Fig. 1).7 Encapsulation by sugammadex immediately 
inactivates these NMBA molecules, rendering them permanently unavailable for redis-
tribution to the neuromuscular junction.8 Sugammadex produces rapid and safe rever-
sal of the commonly used non-depolarizing NMBAs rocuronium and vecuronium.9, 10 
It encapsulates and consequently inactivates these NMBA molecules on a one-to-one 
basis and is able to reverse both moderate and deep or even intense levels of NMB.11-13 
Importantly, sugammadex reversal is much faster and more intense than reversal with 
acetylcholinesterase inhibitors.14 For example, the average time for reversal of a mod-
erately deep neuromuscular block is 2.7 min after administration of sugammadex 2 mg 
kg-1, compared to 17.9 min after administration of neostigmine 50 μg.kg-1.15 In addition, 
sugammadex is well tolerated by patients and is devoid of cholinergic side effects.14, 16 
Sugammadex has been available in Europe since 2008 and has been approved by the 
FDA for use in the USA in 2015.
Although the introduction of sugammadex represents a great improvement in reversal 
of the neuromuscular block, there are some important aspects that deserve consider-
ation. First, only NMB-induced by rocuronium, vecuronium and pancuronium can be 
reversed with sugammadex, leaving acetylcholinesterase inhibitors the only choice for 
reversal of the other NMBAs, such as cisatracurium. In the future, new broad spectrum 
encapsulating agents may become available for all NMBAs.17 Second, the cost of sugam-
madex is significant (in the Netherlands one ampoule of 200 mg costs 78 euro). It is 
unclear whether sugammadex reversal leads to an improved postoperative outcome 
that justifies its cost. The same holds true for another emerging area of interest made 
possible by sugammadex, which is the application of a deep neuromuscular block dur-
ing anaesthesia. With the introduction of sugammadex the use of a deep NMB during 
surgery is now possible without having to fear for prolonged recovery times. Deep NMB 
may improve surgical working conditions for some procedures and allows for a reduc-
tion in insufflation pressures during laparoscopic surgeries.18-21 However, the impact of 
deep NMB on patient outcome is still unclear.
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monitoring depth of neuromuscular block
Neuromuscular monitoring during anaesthesia is most commonly performed using 
the train- of-four (TOF) method.22 Train-of-four peripheral nerve monitors (such as the 
TOF-WatchTM monitor) are usually applied at the distal fore arm to stimulate the ulnar 
nerve. Here, four consecutive supramaximal electrical stimuli (a train-of-four) will evoke 
contractions (twitches) at the m. adductor pollicis of the thumb. Under normal condi-
tions, the amplitude of all 4 motor responses will be equal. With an increasing degree 
of NMB (induced by non-depolarizing NMBAs), the amplitude of the latter twitches 
decreases, relative to the fi rst twitches; a phenomenon called fade.  Eventually, as NMB 
increases, all twitches will become absent (see fi gure 2). Thus, the number of detectable 
thumb twitches and the degree of fading corresponds with the intensity of the NMB. The 
degree of fading can be further expressed as a ratio, by dividing the motor response of 
the fourth twitch (T4) to the fi rst twitch (T1), i.e. the T4/T1 ratio or the so-called TOF ratio. 
Available evidence indicates that the NMB has to be recovered to a TOF ratio of 0.9 or 
greater to allow for safe extubation of the patient.23-27 
When high doses of NMBAs are given, train-of-four measurement at the ulnar nerve will 
show zero thumb twitches (TOF = 0). To measure the degree of NMB in this instance, a 
tetanic stimulus of 50Hz for 5 seconds is applied to the ulnar nerve. The tetanic stimulus 
figure 2. Neuromuscular monitoring. The fi gure shows, from top to bottom, the typical course neuromus-
cular block after a single administration of muscle relaxant (i.e. rocuronium). The above line shows the dis-
appearance of train-of-four twitches after rocuronium administration. The middle part shows the decline 
in post-tetanic-count twitches as neuromuscular block deepens in the fi rst minutes. The bottom line shows 
the return of train-of-four twitches after administration of the reversal agent sugammadex. TOF: train-of-
four; PTC: post-tetanic-count. Blue arrows resemble electrical stimuli
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causes a large amount of acetylcholine to be released in the neuromuscular junction. 
This tetanic facilitation is subsequently followed by 10 - 15 single electrical stimuli 
delivered at 1-s intervals. The number of measured thumb twitches make up the post-
tetanic-count (PTC).28 For example, when 6 thumb twitches are observed following the 
tetanic facilitation, the PTC equals 6 (see figure 2). With TOF and PTC measurements, the 
depth of the NMB can be classified as follows: (1) moderate NMB: TOF count 1-3 out of 4 
twitches; (2) deep NMB: TOF count 0 twitches and PTC > 0 twitches; and (3) intense NMB: 
TOF count 0 twitches and PTC = 0 twitches. 
Postoperative residual curarization
Full recovery of NMB at the end of anaesthesia is essential for the return of adequate 
respiration and upper airway muscle function.3, 29, 30 By definition, PORC is present when 
some level of NMB (TOF ratio < 0.9) persists after extubation. This can readily occur as 
most NMBAs have much longer recovery times than the often-short acting opioids 
and hypnotics used during general anaesthesia. Incidences of PORC range between 20 
and 60% of patients in the post-anaesthesia care unit (PACU).30-32 Residual curarization 
negatively affects pulmonary and upper airway muscle function. It promotes upper 
airway collapse and ventilatory compromise. This is relevant, as even a small degree of 
residual curarization (e.g. TOF ratio between 0.6-0.9) is associated with increased upper 
airway collapsibility and dysfunction of pharyngeal and upper oesophageal sphincter 
muscles.23, 27 Additionally, NMBAs directly block the hypoxic ventilatory response due 
to blocking of nicotinic acetylcholine receptors at the carotid bodies.24 Inhibition of the 
hypoxic ventilatory response renders patients at increased risk for hypoxia. Due to these 
effects, PORC is highly associated with postoperative respiratory complications.3, 29 Use 
of a neuromuscular monitor and adequate reversal of NMB are essential strategies that 
will reduce the incidence of PORC. 
Prevention of postoperative residual curarization
With the use of neostigmine and other acetylcholinesterase inhibitors, a variable degree 
of residual NMB often persists.33 It is therefore not surprising that the effect of NMB-
reversal with neostigmine on postoperative respiratory complications and outcome is at 
best ambiguous. Increasing evidence shows that NMB-reversal with neostigmine (with-
out the guidance of a TOF watch) does not improve postoperative respiratory safety34 
and may even be associated with increased rates of atelectasis,35 hypoxemia36 and 
consequently reintubation37. There are several explanations for these findings. Timely 
administration and exclusive reversal of a moderate NMB are important for successful 
reversal. Evidently, this requires adequate neuromuscular monitoring. In addition, time 
to full reversal following neostigmine treatment displays wide between-patient varia-
tions and is unpredictable. Sugammadex has the potential to do better in both respects, 
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as it allows for fast, complete and predictable reversal of both moderate and deep 
NMB.15, 16, 38, 39 Emerging evidence shows that NMB-reversal with sugammadex reduces 
the rate of postoperative residual curarization compared to reversal with neostigmine 
(see table 1).33, 36, 40 A recent investigation reported a 0% PORC rate in patients reversed 
with sugammadex, versus 46% in those who received neostigmine.40 These results are 
promising, however, in an unmonitored setting PORC after sugammadex reversal still 
occurs in 4% of patients.33, 36, 41 This highlights the need for adequate neuromuscular 
monitoring in any setting where NMBAs are used, regardless the type of reversal agent.
We argue that NMB reversal with sugammadex will decrease the incidence of postop-
erative pulmonary complications by causing complete recovery of ventilatory muscle 
strength. This was shown in two studies in healthy volunteers. Sugammadex-reversal led 
to a higher degree of diaphragmatic and intercostal muscle activation and higher arterial 
pO2 values compared to neostigmine reversal.42, 43 In addition, it is likely that sugamma-
dex will allow for a better return of the hypoxic ventilatory drive, which is attenuated at 
very low levels of residual neuromuscular block.24 Especially in vulnerable patients such 
as the obese and elderly, full recovery of the ventilatory muscles and hypoxic ventilatory 
reflex are crucial to prevent pulmonary complications. Initial evidence from a retrospec-
tive study shows that sugammadex reversal was associated with reduced incidence of 
Table 1. Studies comparing sugammadex and neostigmine on incidence of postoperative residual curari-
zation and pulmonary outcome. 
author Year Design Comparison monitor-
ing
PorC Pulmonary outcome












Available UA Reduced pulmonary outcome 
score in ASA 3-4 patients**
   
Brueckmann40 2015 RCT Sugammadex vs. 
neostigmine
Available 0% vs. 
43.3%**
Respiratory disorders 1.4% vs. 
6.5% #
  hypoxemia 1.4% vs. 2.6%#
   
Boon36 2016 RCT Sugammadex vs. 
neostigmine
No 4% vs. 
70%**
Lowest O2 saturation 93.3 vs. 
96.8%**
   





RCT: randomized controlled trial; UA: unavailable; PORC: postoperative residual curarization (TOF ratio <0.9 
after extubation). *p<0.05, **p<0.001, #p>0.05
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pulmonary complications in elderly ASA 3 and 4 patients compared to reversal with 
neostigmine.44 In a small prospective study, sugammadex-reversal was associated with 
less hypoxemic events in the PACU compared to neostigmine-reversal.36 The current evi-
dence is far from complete and future prospective studies should determine the exact 
value of sugammadex in improving post anaesthesia pulmonary outcome. 
Deep neuromuscular block: prevention of diaphragmatic contractions and 
optimized surgical conditions
Most important advantages of a deep NMB over a moderate block are the loss of (sud-
den) diaphragmatic contractions and significant improvement in surgical conditions 
especially of procedures confined to a narrow space, such as laparoscopic surgery. Vari-
ous studies show that the diaphragm has a high resistance to NMBAs in comparison to 
other muscles.45-47 For example, Fernando and colleagues showed that an intense NMB 
is required to silence the diaphragm in response to stimulation of the carina.45 Similarly, 
Werba and colleagues showed that diaphragmatic responses evoked by tracheal suc-
tioning lead to coughing, bucking and elevated intracranial pressures in neurosurgical 
patients, unless deep NMB was applied.46 In addition, during laparoscopic surgery, ef-
ferent activation of the diaphragm from brainstem chemo-sensitive respiratory centres 
may occur as a result of elevated arterial pCO2 levels (due to CO2 insufflation). Only with 
deep NMB are these diaphragmatic contractions effectively prevented.
Martini et al. assessed the effect of deep versus moderate NMB on surgical conditions 
during laparoscopic retroperitoneal urologic surgery.19 They developed the validated 
5-point Leiden - surgical rating scale (L-SRS, 0-5; extremely poor to optimal working 
conditions) to objectively qualify the quality of the surgical field as experienced by the 
surgeon at various points during the procedure.19, 20, 48 The study showed an improvement 
of 0.7 L-SRS points (mean L-SRS 4.0 vs. 4.7) when deep NMB was applied, an improve-
ment deemed clinically significant by the surgical team.19 In many other procedures, 
a similar effect of deep NMB was found,18, 20, 21, 49-51 but it is important to acknowledge 
that some studies found no effect of deep NMB on surgical conditions (see table 2).52 A 
recent meta-analysis confirmed the positive effect of a deep NMB on surgical conditions 
and reduced postoperative pain scores, however significant heterogeneity between the 
included studies reduces the overall quality of evidence.53 It is important to realize that 
other factors such as deep anaesthesia may positively affect surgical working conditions. 
However, deep anaesthesia, although applicable, is associated with less hemodynamic 
stability and prolonged recovery times. 
Adversaries of deep NMB claim that the gains in surgical conditions with deep NMB are 
modest at best and are not worth the extra effort and cost of the reversal agents (su-
























































































































































































































































































































































































































































































































































































































































gammadex).54, 55 We argue that the observed differences in L-SRS are clinically relevant, 
the incidence of suboptimal conditions is greatly reduced during deep NMB (especially 
the occurrence of sudden diaphragmatic contractions)18-20, 49, and most important, deep 
NMB is associated with less postoperative pain and a reduced incidence of unplanned 
30-day readmission.20, 56 
Finally, there are indications that a deep NMB allows for lower intra-abdominal pressure 
during laparoscopic surgery. Reduced insufflation pressure is associated with less post-
operative pain.57 Deep NMB might cause an increase in abdominal wall compliance and 
consequently an increase in intra-abdominal space.58, 59 However, while various studies 
indeed show that deep NMB allows titration to lower intra-abdominal pressures with 
still acceptable surgical conditions, the gain in intra-abdominal space may be marginal 
59, and the incidence of unacceptable surgical conditions remained substantial higher 
than under standard pressures. The feasibility of low-pressure pneumoperitoneum 
hence needs further investigation. 
ConClusions
Neuromuscular blocking agents have important advantages but also serious disadvan-
tages. Postoperative residual curarization is an important threat, especially in patients 
that are not adequately reversed or monitored. An important new development is the 
introduction of the reversal agent sugammadex. Sugammadex may help reduce the 
incidence of postoperative residual curarization and improve postoperative respira-
tory recovery. In addition, sugammadex enables the use of a deep NMB during general 
anaesthesia. While the deep NMB has been shown to improve surgical conditions and 
reduce postoperative pain in a variety of procedures, its place in anaesthesia is not yet 
fully determined.
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The introduction of sugammadex brought new opportunities in perioperative neuro-
muscular management. Sugammadex enables the application of deep neuromuscular 
block (NMB) and may help to reduce the incidence of postoperative residual curariza-
tion (PORC). This thesis investigated the effect of deep NMB on surgical conditions in 
laparoscopic retroperitoneal surgery using the Leiden - surgical rating scale. In addition, 
outcome data of neuromuscular reversal with sugammadex versus neostigmine and of 
everyday use of deep NMB is presented. 
In Section 1, two randomized controlled trials are presented that investigated the effect 
of deep neuromuscular block on surgical working conditions in laparoscopic urologic 
surgery. Chapter 2 presents data of a randomized controlled trial, which assessed the ef-
fect of moderate (train-of-four count of 1-2 twitches) vs. deep NMB (post-tetanic-count 
of 1-2 twitches) on surgical conditions during laparoscopic retroperitoneal prostatic and 
kidney surgery. These procedures take place in a limited space and it was hypothezised 
that surgical conditions in especially in these procedures may largely depend on ad-
equate muscle relaxation. The primary outcome was the quality of the surgical working 
conditions as rated by the surgeon. For this purpose, the five-point Leiden - surgical 
rating scale was developed (L-SRS: 1. extremely poor conditions to 5. optimal conditions). 
Surgical conditions were rated by the surgeon every 15 minutes after installation of the 
pneumoperitoneum. The main finding of this study was that a deep NMB resulted in a 
higher L-SRS than a moderate NMB (mean L-SRS 4.0 vs. 4.7, p<0.001). In addition, L-SRS 
scores of 3 or lower occurred in 1% in deep NMB vs. 18% in the moderate NMB group. 
This indicates that deep NMB produced superior surgical conditions and significantly 
reduced the incidence of sudden deterioration of the surgical working field.
Although a deep NMB improved surgical conditions over a moderate NMB, the quality 
of the surgical working field varied considerably (e.g. L-SRS scores <5 were noted even 
during a deep NMB). It was hypothesized that variation this could be due to involuntary 
diaphragmic contractions that are triggered by elevated arterial CO2 levels (i.e. hypercap-
nia) induced by CO2 pneumoperitoneum. Chapter 3 presents a study that investigated 
the effect of arterial CO2 levels on surgical conditions in laparoscopic retroperitoneal 
surgery during deep NMB. In this study, patients were randomized to have arterial CO2 
levels maintained at a low level (hypocapnia, pCO2 3.5 – 4.5 kPa) or at a high level (hy-
percapnia, pCO2 6.5 – 7.5 kPa). Primary outcome parameter was the quality of surgical 
field rated on the L-SRS at 15 minutes intervals. The mean L-SRS scores during hypo- and 
hypercapnia were 4.84 vs. 4.77 respectively (p >0.05). Again, 99% of the ratings were 
good (L-SRS score 4) or excellent (L-SRS score 5), irrespective of the randomisation. This 
study confirmed the results of the previous study that deep NMB overall yields good 
surgical working conditions, but the hypothesis suggesting an influence of arterial CO2 
levels on surgical conditions during deep NMB was rejected.
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In Section 2, two outcome studies are presented. Chapter 4 presents retrospective data 
about the everyday use of deep neuromuscular block in laparoscopic retroperitoneal 
surgery. Electronic charts of patients who had received general anaesthesia between 
January 2014 and December 2016 were searched for anaesthetics with the use of high 
dose rocuronium to achieve deep NMB. These cases were matched with respect to sex, 
age and ASA class to patients that had received anaesthesia with low dose rocuronium. 
The primary postoperative outcome was 30-day readmission rate; secondary outcomes 
included duration of surgery and anaesthesia, and postoperative pain. 130 Patients 
were included in each cohort. All patients of the high dose of rocuronium cohort were 
reversed with sugammadex (mean) 267 mg at the end of anaesthesia. In the low dose 
rocuronium cohort 33% of the patients were reversed with sugammadex 212 mg, 20% 
were reversed with neostigmine 1.6 mg. The remainder of the patients were not reversed. 
Postoperative respiratory and pain outcomes, as well as hospital length of stay did not 
differ between the two groups. Unplanned readmission rate was significantly lower in 
the high dose rocuronium cohort compared to the low dose cohort (3.8% vs. 12.7%, OR 
= 0.33, p =0.03). This was primarily due to fewer infectious complications at the site of 
surgery in patients who had received a high dose rocuronium. Prospective studies are 
needed to confirm these findings and to study the effects of a high dose rocuronium/
sugammadex reversal anaesthetic technique on the pharmaco-economic variables.
In Chapter 5, the effect of sugammadex vs. neostigmine reversal on postoperative 
oxygenation was studied. In this randomized controlled trial, 100 patients were ran-
domized for reversal of a moderate NMB with sugammadex 2 mg.kg-1 or neostigmine 
2.5 mg. To mimic real world conditions, neuromuscular monitoring was not allowed. 
Instead, timing of extubation was based on clinical signs of adequate muscle strength. 
In the recovery ward, the use of supplemental oxygen was not allowed unless saturation 
dropped to values below 94%. Patients who had received sugammadex had a mean 
(95% confidence interval) Train-of-four (TOF) ratio at extubation of 0.99 (0.98-1.00) com-
pared to a TOF ratio of 0.74 (0.68-0.80) for patients who had received neostigmine. This 
translated to a mean lowest arterial oxygen saturation of 96.8% (96.1 – 97.4) vs. 93.3% 
(91.9-94.7) in the recovery ward for sugammadex and neostigmine reversed patients 
respectively. Following reversal with sugammadex, 90% of patients had a TOF ratio of 
> 0.9 at extubation and a lowest saturation > 94% at the PACU, compared to 16% of 
neostigmine reversed patients. It was concluded that, in a setting were neuromuscular 
monitoring is not used, reversal of a moderate NMB with sugammadex leads to less 
postoperative residual curarization (TOF ratio <0.9) and less postoperative hypoxemia.
In Section 3, Chapter 6 presents a systematic review of the use of surgical rating 
scales in laparoscopic surgery. After a systematic search in Pubmed, Embase and Web 
of Science, 17 reports were eligible for inclusion. A total of 10 unique surgical rating 
scales were identified. These scales were judged for their quality with the use of a quality 
Summary and conclusions 121
8
score. This score delivered points for optimal length of the scale, description of the scale 
items, validation procedures and correlation with other variables. The overall score of 
the rating scales was low and most scales lacked a validation procedure. In addition, the 
methodology of rating and the reporting of the results differed significantly between 
studies. The only fully validated surgical rating scale for laparoscopic surgery was the 
Leiden - surgical rating scale. A guideline about the construction and use of surgical 
rating scales, as well as for methodology and results reporting was proposed for future 
research.
In the final section, Chapter 7 gives a broad overview about current management 
of neuromuscular relaxation during surgery. Literature was systematically reviewed for 
the latest evidence concerning the effect of sugammadex reversal and the use of deep 
neuromuscular block during surgery on outcome. Increasing evidence shows beneficial 
effects of reversal of NMB with sugammadex over neostigmine and the application of 
deep NMB during certain procedures. If and to what extend this improves outcomes is 
not yet fully determined. Good quality research in this scientific field is scarce, which 
leaves opportunities for the future.
Conclusions
From the data presented in this thesis, the following conclusions can be drawn:
1. Deep neuromuscular block results in superior surgical working conditions compared 
to a moderate neuromuscular block, during laparoscopic retroperitoneal surgery.
2. Superior surgical working conditions during laparoscopic retroperitoneal surgery 
are independent of arterial CO2 levels during deep neuromuscular block.
3. The application of deep NMB is safe and associated with less unplanned postopera-
tive 30-day readmission rates when applied in laparoscopic urologic surgery.
4. Reversal of a moderate NMB with sugammadex results in less postoperative residual 
curarization and less postoperative hypoxemia compared to reversal with neostig-
mine, in a setting were intraoperative neuromuscular monitoring and postoperative 
supplemental oxygen are not allowed.
5. The Leiden - surgical rating scale is a high quality rating scale for assessment of surgi-
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De moderne toepassing van algehele anesthesie (narcose) bestaat uit een drietal pijlers: 
onderdrukking van het bewustzijn (hypnose), pijnstilling (analgesie) en spierverslap-
ping (neuromusculaire relaxatie). Hypnose en analgesie worden beiden verkregen met 
sterke medicamenten die werken op het centrale zenuwstelsel. Neuromusculaire relaxa-
tie wordt verkregen met medicamenten die de signaaloverdracht van zenuw naar spier 
blokkeren. De toepassing van spierverslapping tijdens algehele anesthesie kent vele 
voor- en nadelen. Een belangrijk voordeel is dat spierverslapping een bewegingsloze 
patiënt garandeert tijdens een chirurgische procedure. Zonder spierverslapping is dit 
laatste geen garantie.1 
Het gebruik van spierverslappers kent echter ook belangrijke nadelen. Historisch gezien 
is het gebruik van spierverslapping tijdens algehele anesthesie een onafhankelijke 
risicofactor voor het optreden van ernstige complicaties of overlijden na een operatie.2-4 
Dit heeft te maken met het feit dat spierverslappers lang werkende middelen zijn, in 
tegenstelling tot de overige anesthetica, die vaak kort werkend zijn. Door deze tegen-
stelling in werkingsduur kan het voorkomen dat de spierverslappers in geringe mate 
nog werkzaam zijn, terwijl de anesthesie al beëindigd is. Dit heet restverslapping. Rest-
verslapping is de oorzaak van ademhalingsproblemen op de verkoever en kan ernstige 
complicaties veroorzaken, zoals acute ademhalingsnood of longontsteking.5 Ondanks 
het feit dat deze effecten bekend zijn, komt restverslapping in de praktijk toch nog vaak 
voor, met gerapporteerde incidenties van 20 tot 60% na algehele anesthesie.6
Er zijn verschillende methoden om restverslapping te voorkomen. Een belangrijke 
methode is het bepalen van de mate (diepte) van spierverslapping tijdens een ingreep. 
Hiertoe zijn diverse eenvoudige meetapparaten verkrijgbaar. Al deze apparaten werken 
ongeveer op dezelfde manier: een perifere zenuw (meestal de nervus ulnaris in de 
onderarm) wordt gestimuleerd door middel van een korte electrische stroom, waarna 
het effect van deze stimulatie wordt gemeten in een dichtbij zijnde spier (meestal de 
duim, musculus adductor pollicis). De mate van de opgewerkte spiercontractie is een 
afspiegeling van de mate van spierverslapping. De meest gebruikte meet methode in 
de praktijk is de train-of-four (TOF) methode. Tijdens een TOF meting worden er 4 korte 
stroompjes snel achter elkaar op de zenuw gegeven, welke in een normale situatie 
resulteert in 4 korte spiercontracties (twitches) van de duim. Naarmate de mate van 
spierverslapping toeneemt, zullen de spiercontracties in kracht en aantal afnemen, om 
uiteindelijk geheel te verdwijnen. De relatie van de vierde contractie ten opzichte van 
de eerste contractie kan ook uitgedrukt worden in een ratio, de TOF ratio. Er is sprake 
van restverslapping als de TOF ratio lager dan 0,9 is. Dat wil dus zeggen dat de contractie 
van de vierde twitch, gedeeld door de contractie van de eerste twitch lager is dan 0,9 of 
90%. Vanaf een TOF ratio van 0,9 en hoger is het in het algemeen veilig om de anesthesie 
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te beëindigen en de beademingsbuis te verwijderen. We kunnen nu ook matige neuro-
musculaire blokkade definiëren, namelijk een TOF stimulatie met een reactie van 1 tot 
3 spier contracties; en diepe neuromusculaire blokkade, namelijk een TOF met 0 spier 
contracties. Tijdens een diepe neuromusculaire blokkade kunnen er, door het toepassen 
van een langer durende stroom op de zenuw (een zgn. tetanische stimulus, 5 seconden 
50 Hz.), toch nog spier contracties worden uitgelokt. Dit zijn post tetanische tellingen, 
in het Engels afgekort tot PTC (post-tetanic-count Diepe neuromusculaire blokkade in 
de onderzoeken gepresenteerd in dit proefschrift is gedefinieerd als een PTC van 1-2 
twitches.
Naast het toepassen van neuromusculaire monitoring bestaat er nog een andere 
methode om restverslapping te voorkomen. Dit is het omkeren (antagoneren) van de 
spierverslapping aan het einde van een ingreep. Met antagoneren wordt getracht om 
de spierverslapping aan het einde van de ingreep versneld te doen uitwerken. Hiertoe 
bestaan twee methoden, die hierna kort besproken worden. 
Neostigmine behoort tot de geneesmiddelengroep die de afbraak van acetylcholine 
verminderen (acetylcholinesterase remmers). Acetylcholine is het belangrijkste eiwit 
dat betrokken is bij de signaaloverdracht van zenuw naar spier. Door het remmen van 
de acetylcholine afbraak, neemt de beschikbaarheid hiervan toe. Toename van de 
hoeveelheid acetylcholine leidt tot een versterkte signaaloverdracht. Dit zorgt er voor 
dat het effect van spierverslappers (voor een deel) teniet wordt gedaan. Het gebruik 
van neostigmine kent echter ook nadelen. Ten eerste werkt het traag en is het resultaat 
van antagoneren vaak onvoldoende.6 Bovendien heeft het bijwerkingen, waarvan de 
bekendste een vertraging van de hartslag is. Om dit tegen te gaan is het noodzakelijk 
dat atropine simultaan wordt toegediend. 
Met de komst van sugammadex in het begin van deze eeuw is er echter een nieuwe 
manier van antagoneren beschikbaar gekomen. Sugammadex is een middel wat geba-
seerd is op een een gemodificeerd zetmeel molecuul (gamma cyclodextrine). Sugam-
madex heeft de unieke eigenschap dat het selectief moleculen van spierverslappers kan 
inkapselen (encapsuleren).7 Encapsuleren van deze moleculen, leidt tot een abrupte en 
voorspelbare beëindiging van spierverslapping. Bovendien zijn er nauwelijks bijwerkin-
gen bij het gebruik van sugammadex.8 
Sugammadex opent vele deuren die tot nu toe gesloten waren. Door de beschik-
baarheid van sugammadex is het mogelijk geworden om tijdens operaties een hoge 
dosering spierverslapping te geven (diepe neuromusculaire blokkade), zonder dat dit 
leidt tot een langdurige hersteltijd of een verhoogd risico op restverslapping.9 Diepe 
neuromusculaire blokkade leidt mogelijk tot gunstigere operatie condities voor de chi-
rurg, doordat alle spieren in het operatie veld ontspannen zijn. Bovendien kan, door de 
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hoge effectiviteit van het sugammadex antagonisme, het optreden van restverslapping 
en ademhalingsproblemen op de verkoever mogelijk worden verminderd. Dit zijn de 
belangrijkste hypothesen die in dit proefschrift zijn onderzocht. In de hierna volgende 
paragrafen zullen de afzonderlijke hoofdstukken uit dit proefschrift worden besproken. 
Ter afsluiting zullen de belangrijkste conclusies uit het onderzoek gepresenteerd in dit 
proefschrift worden gepresenteerd.
samenvaTTing
In sectie 1 worden twee prospectief gerandomiseerde studies gepresenteerd die het ef-
fect van diepe neuromusculaire blokkade (NMB) op chirurgische werkomstandigheden 
tijdens laparoscopische urologische ingrepen beschrijven. 
hoofdstuk 2 presenteert de gegevens van een gerandomiseerde studie die het ef-
fect van matige NMB (train-of-four 1-3 contracties) versus diepe NMB (post tetanische 
tellingen 1-2 contracties) op chirurgische werkomstandigheden heeft geëvalueerd 
tijdens kijkoperaties van de prostaat of nier (laparoscopische retroperitoneale prostaat- 
en nier chirurgie). Specifiek deze ingrepen vinden plaats in een beperkte ruimte (het 
retroperitoneum) en de hypothese dat chirurgische werkomstandigheden tijdens deze 
procedures in het bijzonder grotendeels afhangen van de mate van spierverslapping, is 
getest. De belangrijkste einduitkomst was de kwaliteit van de chirurgische werkomstan-
digheden zoals deze tijdens de ingrepen werden beoordeeld door de uroloog. Hiertoe 
werd de vijf-punts Leiden - surgical rating scale ontwikkeld (L-SRS: 1. extreem slechte 
omstandigheden tot 5. optimale omstandigheden). De chirurgische werkomstandighe-
den werden elke 15 minuten beoordeeld door de uroloog. De belangrijkste bevinding 
van dit onderzoek waren dat een diep NMB resulteerde in een hogere L-SRS dan matige 
NMB (4,7 vs. 4,0, p <0.001). Bovendien was slechts 1% van de L-SRS-scores 3 of lager in de 
diepe NMB groep tegen 18% in de gematigde NMB groep. Dit geeft aan dat diepe NMB 
superieure chirurgische werkomstandigheden bewerkstelligd. Bovendien voorkomt 
diepe NMB effectief het optreden van plotselinge verslechtering van het chirurgische 
werkveld door te verhinderen dat een patiënt onverwachts beweegt. 
Hoewel diepe NMB de chirurgische werkomstandigheden verbeterde ten opzichte van 
matige NMB, varieerde de kwaliteit van de chirurgische werkomstandigheden aanzien-
lijk (bijvoorbeeld L-SRS scores <5 werden ook genoteerd tijdens diepe NMB). Dit zou 
te wijten kunnen zijn aan onwillekeurige bewegingen van het middenrif (diafragma) 
tijdens de ingreep. Deze bewegingen kunnen worden veroorzaakt door een verhoogd 
arterieel CO2 niveau (hypercapnie) welke kan ontstaan doordat de buik tijdens een 
kijkoperatie wordt opgeblazen met CO2. CO2 is een krachtige ademhalingsstimulans 
128 Hoofdstuk 9
en kan aanleiding geven tot contracties van het diafragma. Deze contracties kunnen 
zelfs tijdens diepe NMB optreden doordat het diafragma relatief ongevoelig is voor 
spierverslappers. Het verlagen van arteriële CO2 concentratie d.m.v. hyperventilatie zou 
zo bij kunnen dragen aan betere chirurgische werkomstandigheden tijdens diepe NMB. 
hoofdstuk 3 presenteert een onderzoek die het effect van het arteriële CO2niveau op 
de chirurgische werkomstandigheden tijdens diepe NMB weergeeft. Wederom werd dit 
onderzoek gedaan tijdens laparoscopische retroperitoneale nier- en prostaat operaties. 
De patiënten voor dit onderzoek werden gerandomiseerd tussen een groep waarbij de 
arteriële CO2 waarden op een laag niveau werd gehouden (hypocapnie, pCO2 3,5 - 4,5 
kPa) en een groep waarbij het CO2 op een hoog niveau (hypercapnie, pCO2 6,5 - 7,5 
kPa) werd gehouden. De belangrijkste einduitkomst was opnieuw de kwaliteit van 
de chirurgische werkomstandigheden gemeten elke 15 minuten, met behulp van de 
L-SRS. Uit deze studie bleek dat er geen verschil was in de kwaliteit van de chirurgische 
werkomstandigheden tussen de twee groepen. Wederom waren 99% van de beoorde-
lingen goed (L-SRS score 4) of uitstekend (L-SRS score 5), ongeacht de randomisatie. 
Deze studie bevestigt de resultaten van de vorige studie, namelijk dat diepe NMB over 
het algemeen goede chirurgische werkomstandigheden oplevert, maar verwierp de 
hypothese dat het arteriële CO2 niveau hierop van extra van invloed is. 
In sectie 2 worden onderzoeken gepresenteerd die enkele belangrijke einduitkomsten 
na anesthesie beschrijven (postoperatieve outcome). Naar aanleiding van de eerder 
besproken studies, is het gebruik van diepe neuromusculaire relaxatie voor urologi-
sche ingrepen enkele jaren geleden standaard geworden in het LUMC. hoofdstuk 4 
presenteert retrospectieve gegevens over het dagelijks gebruik van diepe neuromus-
culaire blokkade tijdens urologische procedures en vergelijkt deze met de gegevens 
van urologische ingrepen waarbij dit niet is gedaan. Elektronische data van patiënten 
die tussen januari 2014 en december 2016 algehele anesthesie ondergingen, werden 
onderzocht op toepassing van diepe NMB. Deze data werden vergeleken met data van 
procedures waarbij anesthesie werd gegeven met het gebruik van een matige NMB. 
De belangrijkste postoperatieve einduitkomst was het aantal ongeplande heropnames 
binnen 30 dagen na de operatie.
Data van 130 patiënten die algehele anesthesie techniek met diepe NMB hadden 
ontvangen werden gematched met data van 130 controle patiënten die matige NMB 
hadden gekregen. De patiënten die diepe NMB hadden ontvangen waren allemaal 
geantagoneerd met sugammadex in tegenstelling tot 20% van de patiënten die een 
matige NMB hadden gehad. Het aantal ongeplande heropnames was significant lager in 
de diepe NMB groep vergeleken met de matige NMB groep (3,8% vs. 12,7%; p= 0.03). De 
belangrijkste reden voor een ongeplande heropname was infectie in het geopereerde 
gebied (1 patiënt in de diepe NMB groep vs. 7 patiënten in de matige NMB groep). Bo-
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vendien werden er bij de toepassing van diepe NMB geen onmiddellijke postoperatieve 
respiratoire complicaties gezien. Dit onderzoek laat zien dat het gebruik van diepe neu-
romusculaire blokkade tijdens laparoscopische urologische ingrepen geassocieerd is 
met een lagere kans op een ongeplande heropname. Toekomstige prospectieve studies 
zullen deze resultaten moeten bevestigen en moeten uitzoeken of de kosten van het 
sugammadex gebruik opweegt tegen de verminderde kosten van heropnames. 
In hoofdstuk 5 wordt het effect van antagoneren van matige neuromusculaire blokkade 
met sugammadex vergeleken met neostigmine. De belangrijkste einduitkomst van dit 
onderzoek was het optreden van restverslapping (gedefinieerd als een train-of-four ratio 
lager dan 0,9) en de laagst gemeten postoperatieve zuurstof saturatie. Hiertoe werden 
100 patiënten gerandomiseerd voor het antagoneren van matige NMB met sugam-
madex 2 mg per kg of neostigmine 2,5 mg. Om de omstandigheden van de algemene 
dagelijkse praktijk na te bootsen, was neuromusculaire monitoring beschikbaar voor de 
onderzoekers, maar niet voor de verantwoordelijke anesthesioloog. De anesthesioloog 
besloot tot het beëindigen van de anesthesie en het verwijderen van de beademings-
buis (extubatie) op grond van klinische tekenen van voldoende spierkracht en herstel 
van het NMB. Op de verkoever was het gebruik van extra zuurstof niet toegestaan  tenzij 
het zuurstof gehalte (saturatie) zakte onder 94%. 
Patiënten die sugammadex hadden gekregen, hadden een gemiddelde TOF ratio van 
0,99 bij extubatie, vergeleken met 0,74 bij patiënten die neostigmine hadden gekregen 
(p<0.001). Dit vertaalde zich naar een gemiddeld laagst gemeten zuurstof saturatie op 
de verkoever van respectievelijk 96,8% versus 93,3% (p<0.001). Na antagoneren met 
sugammadex had 90% van de patiënten een TOF ratio van > 0,9 bij extubatie en een 
zuurstofsaturatie> 94% op de verkoever, vergeleken met 16% van de met neostigmine 
geantagoneerde patiënten. Uit deze resultaten wordt geconcludeerd dat in een situatie 
waarin neuromusculaire monitoring en extra zuurstof niet wordt toegepast, het antago-
neren van matige NMB met sugammadex vergeleken met neostigmine, leidt tot minder 
postoperatieve restverslapping (TOF ratio <0,9 na extubatie) en minder postoperatieve 
hypoxemie.
In sectie 3 wordt in hoofdstuk 6 een systematische review van het gebruik van chirurgi-
sche beoordelingsschalen tijdens laparoscopische chirurgie gepresenteerd. Na een syste-
matische zoekopdracht in Pubmed, Embase en Web of Science, werden 17 onderzoeken 
geïncludeerd. Een totaal van 10 unieke chirurgische beoordelingsschalen werden geïden-
tificeerd. Deze schalen werden beoordeeld op hun kwaliteit met behulp van een kwali-
teitsscore. De gemiddelde kwaliteitsscore van de geïncludeerde beoordelingsschalen was 
laag en de meeste schalen waren niet gevalideerd. Bovendien verschilden de methoden 
van beoordeling en de rapportage van de resultaten aanzienlijk tussen de onderzoeken. 
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De enige volledig gevalideerde chirurgische beoordelingsschaal voor laparoscopische 
chirurgie was de Leiden - surgical rating scale. Een richtlijn voor de samenstelling en het 
gebruik van chirurgische beoordelingsschalen, evenals voor de methodologie van beoor-
delen en rapportage van resultaten voor toekomstig onderzoek werd voorgesteld.
hoofdstuk 7  geeft een algemeen overzicht van de huidige stand van zake omtrent 
het gebruik van spierverslapping tijdens anesthesie. De literatuur is systematisch beoor-
deeld op de nieuwste gegevens betreffende het effect van sugammadex-antagonering 
en het gebruik van diepe neuromusculaire relaxatie tijdens chirurgie. Toenemend 
bewijs toont dat het antagoneren van spierverslapping met sugammadex kan leiden 
tot minder ademhalingsproblemen op de verkoever. Ook de toepassing van diepe neu-
romusculaire relaxatie tijdens bepaalde procedures brengt mogelijk voordelen met zich 
mee. Echter doordat er weinig kwalitatief goed onderzoek is gedaan, blijft de vraag hoe 
groot deze gunstige effecten zijn en voor welk type ingrepen en patiënten deze gelden. 
Toekomstig onderzoek zal hier uitsluitsel over moeten geven. 
ConClusies
Uit de gegevens van dit proefschrift worden de volgende conclusies getrokken:
1. Toepassing van diepe neuromusculaire blokkade tijdens laparoscopische retro-
peritoneale urologische ingrepen resulteert in superieure chirurgische werkomstan-
digheden in vergelijking met matige neuromusculaire blokkade. 
2. De superieure chirurgische werkomstandigheden tijdens diepe neuromusculaire 
blokkade zijn onafhankelijk van het arteriële CO2 gehalte.
3. De toepassing van diepe neuromusculaire blokkade is veilig en is geassocieerd met 
minder ongeplande heropnames binnen 30 dagen na laparoscopische urologische 
operaties.
4. Omkering van matige neuromusculaire blokkade met sugammadex ten opzichte 
van neostigmine resulteert in minder postoperatieve restverslapping en minder 
postoperatieve hypoxemie, in een situatie waarin neuromusculaire monitoring en 
postoperatieve extra zuurstof toediening niet is toegestaan.
5. De Leiden - surgical rating scale is een hoogwaardige en gevalideerde beoordel-
ingsschaal voor het beoordelen van chirurgische werkomstandigheden tijdens 
laparoscopische chirurgie.
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